2022-04-30-accounts

MOVEMBER EUROPE

MOVEMBER EUROPE Company number: 7275694 Charity number England & Wales: 1137948 Charity number Scotland: SC041981 Charity number Ireland: 20105280

FOR THE YEAR ENDED 30 APRIL 2022

1 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE

CONTENTS

CONTENTS
REFERENCE AND ADMINISTRATIVE INFORMATION	1
TRUSTEES’ ANNUAL REPORT	2
INDEPENDENT AUDITOR’S REPORT	26
STATEMENT OF FINANCIAL ACTIVITIES(INCORPORATING AN INCOME AND EXPENDITURE ACCOUNT) 30
BALANCE SHEET	31
STATEMENT OF CASH FLOWS	32
NOTES TO THE FINANCIAL STATEMENTS	33

MOVEMBER EUROPE

REFERENCE AND ADMINISTRATIVE INFORMATION

COMPANY NUMBER	7275694
CHARITY NUMBER	1137948 (England & Wales)
	SC041981 (Scotland)
	20105280 (Ireland)
REGISTERED OFFICE AND	Gensurco House
OPERATIONAL ADDRESS	52-54 Rosebery Avenue
	LONDON, EC1R 4RP
TRUSTEES	Trustees, who are also directors under company law, who served
	during the year and up to the date of this report were as follows:
	Nicholas Reece (Chairperson)
	Kellie Johnston
	Simon Traynor (resigned 24 September 2021)
	Rob Moodie
	Linnsey Caya
	Deanna Lomas
	Damien Angus
	Cassandra Vujovich-Dunn (appointed 09 February 2022)
	Rochelle Webb (appointed 27	April 2022)
KEY MANAGEMENT	Anne-Cécile Berthier (Country Director – UK & Europe)
PERSONNEL
	Jack O’Connor (Country Manager – Ireland – left 30 November 2021)
	Aisling Farrell (Country Manager – Ireland – joined 11 April 2022, left 17 June 2022)
BANKERS	JPMorgan Chase	Barclays Bank
	25 Bank Street	1 Churchill Place
	LONDON, E14 5JP	LONDON, E14 5HP
	Lloyds Bank	Santander
	25 Gresham Street	2 Triton Square
	London, EC2V 7HN	London, NW1 3AN
SOLICITORS	Russell Cooke LLP
	2 Putney Hill
	LONDON, SW15 6AB
AUDITOR	Sayer Vincent LLP
	Chartered Accountants and Statutory Auditor
	Invicta House, 108-114 Golden Lane
	LONDON, EC1Y 0TL

1 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE

The Trustees present their report and the audited

Reference and administrative information set out on page 1 forms part of this report. The current statutory requirements, the memorandum and articles of association, the requirements of a directors’ report as required under company law, and the Statement of Recommended Practice - Accounting and Reporting by Charities: SORP applicable to charities preparing their accounts in accordance with FRS 102.

2 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

STRATEGIC REPORT

OBJECTIVES AND ACTIVITIES

The Trustees review the aims, objectives and activities of the charity each year. This report looks at what the charity has achieved and the outcomes of its work in the reporting period. The Trustees report the success of each key activity and the benefits the charity has brought to those groups of people that it is set up to help. The review also helps the trustees ensure the charity’s aims, objectives and activities remained focused on its stated purposes.

The Trustees have referred to the guidance contained in the Charity Commission’s general guidance on public and in planning its future activities. In particular, the Trustees consider how planned activities will contribute to the aims and objectives that have been set.

Movember Europe aims to have an everlasting impact on the face of men’s health. Annually, the Trustees review the strategic priorities consistent with the organisation’s vision.

• Movember Europe is part of the Movember Foundation, an independent, global men’s charity with a vision to have an everlasting impact on the face of men’s health. Operating globally, Movember men’s health.

• Movember Europe achieves its organisational goals through both undertaking and strategically investing in research and programmes.

• Movember’s major funded programmes address critical challenges in men’s health and wellbeing, and their treatment and care.

WHAT WE DO:

• Foster and facilitate collaboration

• We want to help those researchers and practitioners focused on our priority men’s health issues to work together towards common goals to enable them to share resources and knowledge. By eliminating overlap and duplication of effort while allowing more resources to be available, we support and accelerate the development of solutions to complex men’s health problems.

3 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

• Understand, promote and advocate for men’s health By making the community aware of the issues around men’s health, we foster an environment that supports men to take action when it comes to their health and wellbeing. We work across a wide population span and tailor approaches for different groups.

• Build evidence about what works and kick-start sustainable approaches Movember Europe has invested resources in innovative programmes that have real and longterm impacts on improving how health promotion is delivered, and how systems of treatment and care are delivered. We continually test and evaluate our approaches, share our learnings and scaling up what works.

• Mobilise men to be more informed, active and connected

Large-scale shifts in complex social problems are best achieved through engaging people across the many environments where they live, learn, work and effective ways of supporting men to be proactive about their health care, and to engage with each other about their health and wellbeing.

• Invest in biomedical, clinical and health services research in prostate cancer and testicular cancer term change can only be achieved by addressing the root causes of how men’s health issues, such as prostate cancer and testicular cancer, arise and the treatments that are available to manage these health issues. Through undertaking and investing in research, we are actively contributing to the search for breakthrough knowledge that accelerates improvements in targeted men’s health issues. We questions that will lead to men living, and not dying from prostate or testicular cancer, and living longer, healthier lives. Through investing in research, we those answers and accelerating improvement in these health issues.

FUNDRAISING STRATEGY

The result that we seek to achieve through our able to deliver on our strategic programme investments, both existing and future, to help us achieve our vision of having an everlasting impact on the face of men’s health.

Although Movember Europe is supported by year-round fundraising efforts by the Movember community, the annual Movember campaign, held in November, is the primary fundraising initiative for the organisation.

During the month of ‘Movember’, we ask supporters to sign up and fundraise by growing a moustache, taking the Move challenge, Hosting an event or ‘Mo’ing their own way’ through an idea of their own. Through their actions they seek donations (with our peer to peer fundraising model) from their networks and consequently not only raise funds but also importantly help spread the organisation’s health messages to their family, friends and colleagues.

INVESTMENT STRATEGY

Movember invests in four priority areas that represent prostate cancer, testicular cancer, mental health and suicide prevention, and men’s health promotion.

PROSTATE CANCER

The result we seek to achieve for men living with and beyond a prostate cancer diagnosis is to ensure access to the treatment and care needed to be physically and mentally well.

Through our education, awareness and investments, prostate cancer mortality and improving health outcomes and quality of life for men diagnosed and living with prostate cancer.

We seek to achieve this by investing in biomedical, translational, clinical, health services, quality improvement and education initiatives that will:

• Lead to non-invasive or minimally invasive tests to accurately diagnose prostate cancer.

• Lead to the provision of effective and optimal patientcentred treatments.

• Lead to interventions that reduce or minimise treatment-induced side effects.

• Lead to non-invasive or minimally invasive tests to monitor prostate cancer and its progress.

• Accelerate medical discoveries that lead to interception of lethal disease.

• Lead to clinical trials, tests, treatments, and interventions that cure or slow disease progression.

• Lead to the development and evaluation of clinical interventions.

4 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

• Provide population-based transparency on health outcomes.

• Catalyse new models of care that can sustainably scale.

• Provide supportive care to men and their families.

• Provide education to men on when and how to take action.

TESTICULAR CANCER

The result that we seek to achieve is that men and boys living with and beyond testicular cancer have access to the information, resources, treatment and care they need to be physically and mentally well. We aim to invest in:

Biomedical, translational, clinical, health services, care and education initiatives that will:

• Lead to a better understanding of the biology of the disease and the causes of progression, relapse and treatment resistance.

• Lead to interventions that reduce or cure side-effects of the disease or its treatment.

MENTAL HEALTH AND SUICIDE PREVENTION

The results that we seek to achieve are to contribute to boys and men having improved mental health and wellbeing and a decreased rate of suicide.

We fund and deliver programmes that lead to men staying mentally well, being socially connected, having meaningful conversations and taking action during tough times.

Our programme investments include:

• Strengthening the evidence of what works for priority and socially isolated men.

• Scaling into a real world environment evidence based community, digital and mass media programmes to accelerate the reach and impact of our work.

MEN’S HEALTH PROMOTION

Our Health Promotion Plans address the following challenges consistent across all of our cause areas.

The need for men to:

Health outcomes research and initiatives that:

• Lead to a better understanding of the needs of men and boys facing diagnosis, treatment and care.

• Provide practical support to men and boys when required.

• Catalyse new models of improving the health outcomes of men and boys that can scale within and across countries.

• Educating men and boys on diagnosis, treatment, and care and how to take action on their health.

• Be aware of the physical and mental health risks they face, at different ages and stages of life.

• Recognise the signs and symptoms of not doing so well or being unwell.

• Take action early when they experience physical, mental, and social problems.

• Build and maintain a strong social network around them.

5 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

ACHIEVEMENTS AND PERFORMANCE

The charity’s main activities and who it tries to help are described below. All its charitable activities focus on men’s health and are undertaken to further Movember

The table below presents the major initiatives Movember continues to fund in the UK, along with a summary of key achievements and performance of programmes.

Project	Achievements	Achievements	Achievements	Achievements	Achievements
TRUE NORTH (UK)	True North is				a collaborative prostate cancer program funded and created by Movember, aimed
	at improving				prostate cancer care			for all men. The True North Survivorship Pilot																		Projects were
	designed to improve the quality of life and													long-term outcomes among men with prostate cancer,
	their partners and families. Eight projects received funding in the UK. The project drew																											to a	close in
	2021 and the				most promising	initiatives are now										being scaled by						our	men’s health partner PCUK.
PROSTATE CANCER	We support national and international initiatives that aim to																				reduce variation			in treatment quality
CLINICAL QUALITY	across		all stages of prostate cancer. The TrueNTH Global Registry and IRONMAN Registries involve
	clinical sites across the UK. These							programmes measure, benchmark and improve the																			quality of
	prostate cancer treatment and care.
CENTRES OF EXCELLENCE:	Belfast-Manchester Centre of Excellence brings															together an international team of experts in
BELFAST-MANCHESTER	radiation, biomarker discovery, genetic										modelling and tumour biology in the FASTMAN																	programme
	that aims to improve the effectiveness of treatment for men with high-risk, locally advanced
	prostate cancers and prevent					disease recurrence											(progression to metastatic disease).
CENTRES OF EXCELLENCE:	London Centre of Excellence has						improved diagnostic												tests including the better use of magnetic
LONDON CONSORTIUM	resonance imaging that allows more accurate detection of small																					volume tumours, as well as tissue-
	and blood-based biomarkers that can be used to identify men at																					high risk of aggressive disease and
	so allow			better treatment choices				based				on each man’s genetic information.
TRANSLATIONAL	This programme is aimed at accelerating the development of diagnostic tools that will improve the
RESEARCH AWARDS	outcomes for men with prostate cancer.											A total of					six awards have been made under this scheme.
PRECISION MEDICINE	The primary focus of this programme is										to			obtain the evidence required to support novel biomarker-
AWARDS	treatment pairings for men newly diagnosed with advanced prostate cancer. It is proposed that by identify the treatment that they are most likely to respond to and improve outcomes.
RESEARCH INNOVATION	This programme aims to support						the most							impactful				and innovative proposals							across a			broad
AWARDS	spectrum of prostate cancer research areas. Selected																		projects will approach research questions
EXISTING TRIALS	The Major Awards looks to utilise and interrogate																existing patient samples and/or data											from recently
NEW ANSWERS	completed or ongoing prostate cancer clinical trials,																	or from other samples and/or data repositories.
MAJOR AWARDS	Capitalising on these existing					resources, the Awards												must seek to answer new							and innovate				research
MAJOR AWARDS IN
CURATIVE TREATMENT	potential of curing non-metastatic prostate cancer.
RESEARCH HIGHLIGHTS
FOR 2021/2022	table below on page 12) of all ongoing and recently closed out research projects in the UK.
GLOBAL ACTION PLAN	In addition, Movember continues						to		invest					in our Global Action Plan (GAP) programmes. Since 2012,
PROGRAMMES	Movember has established seven consortia that															foster international collaboration in translational
	research to address critical challenges in prostate and testicular cancer.
HEALTH PROMOTION	A core part of Movember Europe’s health												promotion					work is			to empower men			with the			awareness,
	knowledge, and resources to take positive who appeal to this demographic.													action for				their health through the						annual Movember

6 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

Project	Achievements
DIGITAL RESOURCES	Part of Movember’s strategy is to deliver digital tools and services that improve the lives of men
	with prostate cancer, testicular cancer and track key life stages to improve men’s mental health.
	In the UK, these include Movember’s Family Man, an online parenting programme; Movember
	Conversations, a conversation support tool; and Nuts&Bolts, a resource for men recently diagnosed
	with testicular cancer.
SOCIAL INNOVATORS	The Social Innovators Challenge (SIC) project is focused on increasing our understanding about
CHALLENGE	what engages men to build strong social connections, particularly those who are at risk of becoming
	socially isolated. Of the four projects that have been funded in the UK, one is being scaled and the
	other three are receiving funding extensions		until 2023.
VETERANS AND FIRST	This global programme is focused on identifying promising mental health or suicide prevention
RESPONDER MENTAL
HEALTH GRANTS	increased risk of poor mental health and suicide. There are three projects in the UK receiving grants.
PROGRAMME
DIGITAL SOCIAL	This global programme is focused on ideas that strengthen the social connections of men who were
CONNECTIONS CHALLENGE	struggling with isolation and anxiety, in the wake of COVID-19 lockdowns. In the UK, four projects are
	being co-developed with Movember.
DISTINGUISHED	This global project is focused on developing ideas that improve the social connectedness, life
GENTLEMAN’S RIDE SOCIAL	satisfaction and mental wellbeing of motorcycle riders. In the UK, three projects have received
CONNECTIONS CHALLENGE	funding as part of this programme.
AHEAD OF THE GAME	Ahead of the Game is an evidence-based programme that uses community sport to teach
	adolescent athletes, parents and coaches how to talk about mental health and seek support.

ACHIEVEMENTS AND PROGRESS

The True North Supported Self-Management and Follow Up Care project, led by the University of Southampton, worked in partnership with the University of Surrey and

TRUE NORTH UK

The True North Survivorship Pilot Projects were a set of 27 interventions designed to improve the quality of life and long-term outcomes among men with prostate cancer, their partners and families. The interventions were designed to support and guide men through the prostate cancer journey and transform the way they make decisions, receive care, manage symptoms and share lived experiences. In the UK, the programme was managed by our men’s health partner Prostate Cancer UK.

Eight projects received funding and they focused on: continence management; exercise and diet; needs assessment and care planning; support for men postradiation; support for men postsurgery; sexual wellbeing; supported self-management; and decision support. The received in February 2021. The most promising initiatives below are now being scaled by Prostate Cancer UK.

Supported Self-Management

Men with a diagnosis of prostate cancer report high levels of unmet needs in the months and years that follow treatment, despite regular follow up clinic attendance. Some report feeling “abandoned” by the healthcare system once their treatment is complete.

Men who took part in the programme had access to a support worker, an online patient service that allows them to check test results, complete assessments, view their patient information and message their clinical team. They attended a four-hour workshop to develop condition. They continued to have their disease closely monitored by their clinical team but were freed from attending routine appointments unless an issue arose.

The results of the project showed that physical health outcomes for men were similar to the usual standard of care. Men receiving supported self-management of life and reductions in unmet needs compared with usualcare. The new model of follow up was perceived by men and the clinical team to have improved the quality off provision for follow up.

In addition, clinicians were able to spend more time with patients with complex needs. The evaluation also stated that supported self-management was perceived to have improved the safety of follow-up care due to the robust callrecall system, PSA tracker and increased staff capacity to support men to comply with PSA testing schedules.

7 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

As of February 2021, over 3,000 men had enrolled on the SSM follow-up pathway and more than 300 supported selfmanagement workshops had been delivered. The pathway is now provided as an example in NHS England guidance supported by the NHS England plans. As of April 2020, (PSFU) has been mandated for colorectal and prostate cancer as part of a national “outpatient transformation”. A recent analysis by Prostate Cancer UK found that the SSM 13 Cancer Alliances in England. In addition, the pathway is the accepted model of follow up across Wales along with working with one of the three Cancer Networks in Scotland to implement SSM across their locality.

Maximising Sexual Wellbeing

cancer treatment is reduced sexual function, which can have a negative impact on intimacy, relationships, and men’s self-esteem. Movember supported The True North Sexual Wellbeing pilot project which was aimed at facilitating more effective communication between healthcare professionals and men who were facing sexual sexual problems resulting from prostate cancer treatment.

The project was completed in December 2019 and an evaluation of the sexual health self-management resource EASSi tool showed that men experienced understanding of how to manage the impact of prostate cancer treatment on their sex life and their belief that

they could have a satisfying sex life following prostate cancer treatment.

To support the scaling phase, the health care professional training package is being promoted through Prostate Cancer UK’s healthcare professional network. By December 2019, the module had been used by 103 healthcare professionals and resulted in changes in attitudes and beliefs around sexual wellbeing regarding men with prostate cancer. In addition, the online selfmanagement programme is being disseminated to men and partners through PCUK’s specialist nurses and patient online forum.

PROSTATE CANCER CLINICAL QUALITY

TrueNTH Global Registry

Operating internationally across 13 countries, the TrueNTH Global Registry (TNGR) is a project that aims of men with prostate cancer. By harnessing new and existing prostate cancer registries and organisations which are systematically collecting clinical data and measuring patient reported outcome measures (PROMs) at baseline and 12 months post treatment, this clinical quality initiative seeks to improve patient outcomes by reducing variation in treatment quality, identifying centres of clinical excellence and providing risk adjusted outcomes data to physicians in the form of Quality Indicator Reports. In the UK there are nine hospitals participating in the project. More information regarding TNGR can be found at tngr.movemberhealth.org

8 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

IRONMAN Registry

IRONMAN is an International Registry for men with advanced prostate cancer that is currently recruiting across 107 active sites in 11 countries. In the UK, 10 hospitals are participating in the project. The IRONMAN registry collects information about a man’s type of prostate cancer,their treatment, and their experiences in an effort to understand the disease and learn how to stop or slow disease progression. By collecting clinical information and blood samples periodically, the registry seeks to understand which treatment and care practices deliver the best outcomes for men with advanced prostate cancer.

The project seeks to:

• Describe real world practice patterns for six new treatments internationally

• Identify treatment sequences or combinations associated with optimal survival and patient- reported outcomes

• Assess whether treatments are associated with toxicities and co-morbidities

• Develop prospective blood biobank for clinical and biological characterisation of disease subtypes

• Create international partnerships to work together to identify unmet needs in advanced prostate cancer, including quality of life.

1,865 men enrolled in the registry showed that men diagnosed with advanced prostate cancer face a range of symptoms that affect their quality of life and overall health, including fatigue, anxiety and reduced physical functioning, such as being able to take a short walk.

More information on the IRONMAN Registry can be found at ironmanregistry.org

MOVEMBER CENTRES OF EXCELLENCE

The London Centre of Excellence is pursuing research to improve clinical care from the diagnosis, management and treatment of prostate cancer through personalised precision medicine approaches. The programme has focused on (1) identifying risk factors for aggressive prostate cancer for targeted screening approaches, (2) developing germline and tumour biomarkers related to primary treatment resistance and/or sensitivity in locally advanced disease and (3) qualifying biomarkers to enable better treatment and outcomes for aggressive prostate cancer.

The Belfast-Manchester Centre of Excellence has enabled the development of a large multidisciplinary team of research experts to focus on the development of a comprehensive radiotherapy-focused research

programme through a number of linked work packages. The establishment of the Centre has transformed prostate cancer research in Belfast and Manchester, with three thematic programmes building on from the original FASTMAN programme, including (1) development of biomarkers that can inform radiotherapy resistance, (2) improve understanding of the drivers that lead to disease relapse post-radiotherapy through comprehensive tumours that can and cannot be detected through imaging modalities, and (3) improving radiotherapy through the use of novel interventions.

The transformative nature of the two Movember Centres with both Centres having prioritised the delivery of research impact to men with prostate cancer.

• The total amount of funding leveraged on the back of the initial investment reached £20.4m from a wide variety of sources in the UK and internationally.

• The Centres have already played a contributory role in knowledge sharing, with 289 publications in peerreviewed journals and over 16,800 citations.

• The Centres have prioritised the delivery of research impact to men with prostate cancer through the clinical trials.

The Belfast-Manchester programme was completed in in September 2022. The London Programme will continue until June 2023.

TRANSLATIONAL RESEARCH AWARDS

By building on previous research that has real potential to make the leap from ‘bench-to-bedside”, this programme aimed to accelerate the development process of diagnostic tools that will improve the outcomes for men with prostate cancer. A total of six awards have been made under this scheme and, while the awards are either still ongoing or have been completed in recent years, they have led to the substantial research outputs, including the activation of four clinical trials, the in leveraged funding to support subsequent development of the research.

PRECISION MEDICINE AWARDS

Metastatic prostate cancer remains incurable despite recent advances in the landscape of available treatments, with many thousands of men continue to suffer and die from this disease. It has been proposed that the inter-individual

9 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

factor, where clinicians have little idea as to which treatment will work best for which men (depending on the unique characteristics of his disease). This programme therefore aimed to support the optimisation of biomarkers to inform precision-treatment selection for men with advanced disease. Both projects funded under this programme are ongoing and will start to report research results in 2023.

RESEARCH INNOVATION AWARDS

This programme aims to encourage innovative proposals across a broad spectrum of prostate cancer research, where both fundamental and clinical research (and all stages in between) would be considered for funding if there is a clear Both projects funded under this programme are ongoing and are expected to be completed in 2023.

MAJOR AWARDS: EXISTING TRIALS, NEW ANSWERS

Over the past decade, many clinical trials have and are taking place internationally to change the way prostate cancer is diagnosed and treated. Many of these trials have not only produced practice-changing results but also amassed large quantities of clinical data and patient samples which hold huge potential to address critical research unmet needs. This programme was established with the aim to utilise and interrogate existing samples and/or data from recently completed or ongoing prostate cancer clinical trials, or from other sample / data repositories, to answer new and the outcomes of men with prostate cancer. A total of three projects that were funded under this programme commenced research activities in FY22 and will continue until FY24.

10 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

MAJOR AWARDS IN CURATIVE TREATMENT

This programme was initiated with the notion that, if prostate cancer is caught in time, when it is still localised to the prostate (or has only spread to the area just outside the prostate), we may be able to cure the disease with existing treatments. This has therefore been recognised as a much-needed focus to improve outcomes for men with associated adverse effects that could impact on men’s quality of life. The programme called for proposals that aim to help men select the most appropriate treatment, to increase the effectiveness of initial treatment in terms of disease control, or to reduce side effects from initiation treatment without compromising on the disease control. projects have been funded under this programme to explore the potential of curing non-metastatic prostate cancer.

RESEARCH HIGHLIGHTS FOR 2021/22

1. Novel imaging technique that successfully prostate cancer, offering the potential to reduce over-treatment of indolent disease and a way to detect disease progression early in men on active surveillance - 2013 Pilot Award to Ferdia Gallagher

The use of mpMRI has transformed the way in which men are diagnosed with prostate cancer in the UK. men who are being over diagnosed and as a result are experiencing side effects from their treatment which could have been avoided, as well as a number of men whose prostate cancer progresses whilst on active surveillance. Therefore, there is a pressing need to differentiate more accurately indolent from clinically aggressive prostate cancer.

Dr Ferdia Gallagher and his colleagues based at the Addenbrookes Hospital and the University of Cambridge tested a novel form of imaging, known as Hyperpolarised[13] Carbon MRI , which allows researchers detect subtle differences within tumours with the same grade and provided the critical information to determine which men need immediate radical treatment, as compared to men suitable for active surveillance.

With further funding secured from Cancer Research UK, the team will progress to validate this technique in a much larger group of men. Scaling up the project could allow the technology to become part of a routine scan with the potential to be rolled out across the UK within 10 years.

1. cancer early – 2019 Research Innovation Award to Colin Cooper

Prostate cancer varies between different men. For some, their cancer is aggressive and will need treating straight away. Other men’s cancers are slow growing and can be left untreated, avoiding unnecessary side effects associated with treating prostate cancer. Current standard practice includes prostate biopsies to determine whether men’s cancers are aggressive, which itself can be invasive and cause complications.

Professor Colin Cooper and his team are developing a prostate cancer urine test, the Prostate Urine Risk (PUR) signature, which could determine whether prostate cancer is aggressive or not – with the potential to spare some men from unnecessary biopsy.

The team has also developed a protocol that retains stability of the signatures secreted in the urine, turning the PUR test into an ‘at-home’ test kit and have the urine sample posted to the lab for analysis. In combination with the ability of the PUR signature to predict the aggressiveness of a cancer before a biopsy is taken, the test could potentially allow the treatment) without them having to visit a GP or hospital.

1. Finding the men who will respond well to PARP inhibitor (a new drug approved for men with advanced disease in 2020) – 2013 Clinical Research Training Fellowship to Joaquin Mateo

Some men with advanced prostate cancer respond very well to PARP inhibition, but for some men no depends on the DNA repair defects found in men’s prostate cancer and they can differ from man to man. A greater understanding of how different DNA repair defects effect a man’s response to PARP inhibition will enable better personalisation. By using cutting edge

The team found that men who have both copies of BRCA2 deleted in their prostate cancers had the best response to treatment with PARP inhibition – with an average overall survival time of 22.2 months, 7.5 months longer than men who had a mutation in either BRCA1 or BRCA2.

The team is now continuing to build on these results and ensure we can improve the PARP inhibitor treatment strategy with further Movember support (2018 Major Awards in Existing Trials New Answers).

11 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

BIOMEDICAL RESEARCH PROJECT INFORMATION

Program Name	Principal Investigator Administering Institution Project Title Research Focus
2013 MOVEMBER CENTRES OF EXCELLENCE	Johann de Bono Institute of Cancer Research London Centre of Excellence All disease stages / Precision Medicine
	Joe O’Sullivan / David Waugh Queen’s University Belfast Belfast-Manchester Centre of Excellence High-risk localised PC / Improving radiation therapy
2015 TRANSLATION AL RESEARCH AWARD	Andrew Feber University College London Development of a cfDNA epigenetic biomarker for the detection and surveillance of prostate cancer Disease diagnosis / Prognostic biomarkers (PACEB test)
	Gerhardt Attard Institute of Cancer Research PARADIGM trial: using Plasma AR gene status to select between AR targeting therapy and Docetaxel or cabazltaxel for progressing metastatic prostate cancer Disease progression / Predictive biomarkers (AR in cfDNA)
2016 PRECISION MEDICINE AWARD	Gerhardt Attard Institute of Cancer Research Treatment-Oncomarker Pairing of STAMPEDE Patients starting long- term Hormone Treatment (STRATOSPHere) Disease progression / Predictive biomarkers
	Johann de Bono Institute of Cancer Research Transforming lethal prostate cancer care through disease molecular biomarker analytic validation and mCRPC / Predictive biomarkers
2016 TRAVELLING PRIZE FELLOWSHIP	Susan Heavey Institute of Cancer Research SCREEN: utilisation of co-targeted therapy in prostate cancer High-risk localised PC / New therapy (PIM inhibitor + AR / PI3K targeting therapies)
2019 RESEARCH INNOVATION AWARD	Colin Cooper University of East Anglia outcome in prostate cancer patents Disease diagnosis / Prognostic biomarker (PUR test)
	Johann de Bono Institute of Cancer Research Targeting the heat shock factor-1 stress response to abrogate persistent androgen receptor (full length and splice variant) mCRPC / New therapy (HSF-1 inhibitor)
2019 EXISTING TRIALS NEW ANSWERS	Freddie Hamdy University of Oxford Deciphering features of lethal disease in the ProtecT study diagnostic samples High-risk localised PC / Prognostic biomarker (prostate biopsy)
	Gerhardt Attard Institute of Cancer Research of locally advanced high-risk prostate cancer treated in the STAMPEDE trial: discovery and validation of a clinically implantable test for precise treatment High-risk localised PC / Prognostic biomarker (prostate biopsy)
	Johann de Bono Institute of Cancer Research Improving outcome from aggressive prostate cancer with DNA repair defects through biomarker studies mCRPC / Companion diagnostic for PARP inhibitors (cfDNA)

12 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

Program Name	Principal Investigator Administering Institution Project Title Research Focus
2020 MAJOR AWARDS IN CURATIVE TREATMENT	Alan McWilliam University of Manchester ratio for men with prostate cancer undergoing radical radiotherapy High risk localised PC / Improving therapy (Radiotherapy; Risk
	Bill Nailon / Duncan McLaren Edinburgh Cancer Research Centre Improving radiotherapy in PROState cancer using EleCtronic population- based healthCAre data: The PROSECCA study, answering new questions in prostate cancer High-risk localised PC / Improving therapy (Radiotherapy; using AI/ML on EMR)
	Emma Hall / Angela Pathmanathan Institute of Cancer Research PACE-NODES - A randomised trial of 5 fraction prostate radiotherapy (SBRT) or 5 fraction prostate and pelvic nodal SBRT in patients with high risk localised prostate cancer High-risk localised PC / Improving therapy (Pelvic nodal + Prostate radiotherapy)
	Young-Jie Lu / Greg Shaw Queen Mary University of London Circulating tumour cells as biomarkers for treatment cancer High-risk localised PC / Prognostic biomarker (CTC)
	Valentine Macaulay University of Oxford Investigating IGFs as drivers of treatment failure in localised prostate cancer High-risk localised PC / New therapy (IGF inhibitor)
2016 TRAVELLING PRIZE FELLOWSHIP	Chris Armstrong Queen’s University Belfast Jul 2017 – Dec 2020 YKL40 signalling as a mechanism of relapse following radiotherapy in High-risk localised PC / New therapy (YKL40 inhibitor)
2014 TRANSLATION AL RESEARCH AWARD	Ananya Choudhury Christie Hospital Manchester Feb 2016 – Jan 2021 Translating companion hypoxia response-predictive biomarkers into clinical practice in prostate cancer High-risk localised PC / Predictive biomarker (hypoxia signature)
	Dow-Mu Koh Royal Marsden University Jul 2015 – Mar 2018 Development of response and prognostic imaging biomarkers using whole body diffusion- weighted MRI for metastatic bone disease of patient with CRPC mCRPC / Improving imaging (wb-dw MRI)
	Hayley Whitaker University College of London Jan 2016 – Sep 2019 Using imaging, blood and urinary biomarkers to improve the diagnosis of aggressive prostate cancer Disease diagnosis / Improving imaging (mpMRI)
	Hing Leung University of Glasgow Nov 2015 – Nov 2019 Combined suppression of cholesterol bioavailability and androgen deprivation therapy to treat CRPC mCRPC / Optimising therapy (ADT + statin)
2015 PHD STUDENTSHIP	Daniel Brewer / Claudia Buhigas University of East Anglia Oct 2016 – Sep 2019 The application of genome DNA sequencing technologies to understanding why prostate cancer is usually multifocal Disease biology / Genomic analysis on clonal expansion
	Johann de Bono / George Seed Institute of Cancer Research Apr 2016 – Sep 2019 Integrative prostate cancer genomics to improve CRPC mCRPC / Prognostic biomarker (bioinformatics)
	Robert Bristow / Ronnie Rodrigues Pereira University of Manchester Oct 2016 – Oct 2021 as biomarkers of patient response to therapy High-risk localised PC / Prognostic biomarker
	Hector Keun / Sharmlia Rhana Imperial College London Oct 2016 – Nov 2020 Systematic analysis of predictive and prognostic miRNA-mRNA networks in prostate cancer High-risk localised PC / Prognostic biomarker (miRNA)

13 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

MOVEMBER’S GLOBAL ACTION PLAN

GAP4 – Exercise and Metabolic Health in Prostate Cancer

Through a global collaboration of participating clinical study sites, GAP4 will execute a large-scale, multi-centre, multinational pivotal clinical trial designed to test the effects of exercise on prostate cancer progression. supervised intense exercise and psychosocial support increases patient survival compared to self-directed exercise and psychosocial support in men with metastatic prostate cancer.

The aim is for 866 men to be recruited into the trial (433 randomised to supervised exercise and 433 randomised to self-directed exercise) across approximately 30 clinical

Each clinical site will have a multi-disciplinary team of oncologists, exercise physiologists and study coordinators who will recruit the men and facilitate their exercise regimen.

Guy’s & St Thomas’ NHS Trust have been engaged to act as the local sponsor and coordinating lead site for the UK UK sites are:

• Dr Mieke Van Hemelirijck and Dr Sarah Rudman – Guy’s and St Thomas’ Hospital & King’s College London

• Dr Suneil Jain – Queen’s University Belfast & Belfast City Hospital

• Dr Hing Leung - University of Glasgow

• Dr Ralph Manders - University of Surrey

• Dr Rebecca Jones - University of Bedfordshire

due to COVID-19 but a new trial protocol is now in place that broadens patient eligibility and allows men to take part in exercise remotely to boost recruitment.

GAP5 - Testicular Cancer: The TIGER Trial

Movember is funding the European and Australian contribution to a large, multi-national clinical trial investigating the impact of high dose chemotherapy against conventional chemotherapy on overall survival chemotherapy for relapsing testicular cancer. This trial is a large scale, multinational effort in a particularly rare patient population. The trial is managed in the US and Canada by the Alliance for Clinical Trials in Oncology. The European and Australian contribution is organised and managed by the European Organisation for Research and Treatment of Cancer (EORTC) and the Australian and New

Zealand Urogenital and Prostate Clinical Trials Group (ANZUP) and funded by Movember. To date, 389 men and boys – 230 from the EU, 147 from the US and 12 from trial participant expected to join by August 2022. The sites participating in the TIGER trial from the UK are:

• Leeds, Saint James’s University Hospital (Dr Stark)

• Weston Park Hospital (Dr Young)

• St. Bart’s Hospital (Dr. Shamash)

• Southampton General Hospital (Dr Wheater)

• The Royal Marsden (Dr Huddart)

• Beatson West of Scotland (Dr. White)

• Manchester, The Christie (Dr. Welch)

• Nottingham City Hospital (Dr. Hennig Ivo)

MEN’S HEALTH PROMOTION

Our Health Promotion strategy seeks to improve the health outcomes of vulnerable men, at scale, and contribute to the reduction in the number of men dying prematurely. Using mass media communications, we aim to create positive behaviour change in men. Movember’s Health Promotion work in 2021/22 operated at two levels:

The Movember Campaign

During the 2021 Movember campaign, we continued to ask supporters to sign up and fundraise by growing a moustache, taking the ‘Move’ challenge, hosting an event or ‘Mo-ing their own way’ with an idea of their own to fundraise. Their actions not only raise funds but also equally importantly deliver on our awareness and education objectives, to raise awareness and understanding of the health risks men face and result in men taking action to remain well.

Based on the results of a 2021 research project we know that men who take part on Movember are more likely to take part in healthy behaviours including speaking to others about their wellbeing, being physically active, a friend. This research was also shared with men this “Movember is good for you” section of the website and 2.5million people engaging with the campaign content.

These results reinforce the importance of salient, well timed health information presented throughout the month of Movember as men participate and engage with the annual campaign. Movember.com continues to be the centralised location for all health promotion content, campaigns, tools, and resources.

14 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

Global research carried out by Movember early in the backgrounds as being among those suffering the lowest levels of wellbeing and highest levels of distress. Using insights gathered from the research, Movember number of followers from this demographic to create a content series demonstrating the importance of talking openly about mental health with friends.

Building on the success of the 2021 pilot study, an optimised YouTube content series was launched in 2022 aimed at supporting young men from lower-income backgrounds to have more meaningful conversations with a close friend.

Focusing on the subscriber base for some of the UK’s leading YouTubers, a new creative approach entitled ‘Come Check Me’ asked creators to model shoulder-to shoulder conversations whilst on a journey, opening up to a friend they can be themselves with, by sharing their feelings about life’s pressures and demonstrating the their friendship.

Hosted on YouTube with supporting content on Instagram allowing for evaluation of desired dosage alongside a longitudinal study measuring real word behaviour change. The video series is expected to reach over 8 million men whilst building on the 650K online engagements from last year. Initial reaction to live content has shown men are connecting with the conversation and showing a positive response to changed behaviour.

DIGITAL RESOURCES

Movember Family Man

online parenting programme designed with dads in mind and aimed at helping fathers to engage in the parenting knowledge.

The free, online course was initially designed to equip parents of children, aged between two and eight, with the practical skills to manage challenging child behaviour and

However, as the product continues to evolve, the intention is to include content that helps parents of children and adolescents between the ages of 9-16 years old. The evidence-based programme, which has been vetted by a global panel of psychologists and parenting experts,

currently consists of three 15-minute interactive episodes focusing on reinforcing positive behaviour, managing misbehaviour, and managing high-risk situations. Other features include quiz exercises that helps users to reinforce learnings from the episodes, 21 content articles including how to manage tantrums and dealing with sleep problems in young children, among others. From May 2022, parents will be able to sign up to receive daily parenting tips via text message over the course of 15 days. Since September 2020, 200,000 users have visited the Family Man site – 56 per cent of whom identify as fathers. Around 90 per cent of users said Family Man increased their knowledge of positive parenting while 79 per cent said the programme increased their ability to manage their child’s behaviour. More information can be found at: familyman.movember.com

Movember Conversations

Launched in 2020, Movember Conversations is a free interactive digital tool that offers practical guidance on how to have more effective conversations with men who may be struggling with their mental health.

Guided by an international team of mental health experts, the tool uses simulated conversations to explore different scenarios – such as job loss or isolation. It demonstrates to the user that by changing the way they respond even subtly, it can lead to deeper, more meaningful conversations. It focuses on skills such as learning how to frame questions appropriately, asking open-ended questions and practising non-judgemental responses.

As of January 2022, Movember Conversations has received over 413,000 visitors to the site and over 348,000 conversations have been started. Most users reported that they found the tool to be useful (90 per cent), and that they learned something (88 per cent).

Follow-up survey results suggest that respondents are having approximately two conversations with men using what they learned within two weeks of their experience. More information can be found at conversations.movember.com

Nuts & Bolts

A core part of Movember’s mission is to ensure that no man goes through testicular cancer without the information and support they need and a community to reach out to. However, Movember research has shown that although getting a testicular cancer diagnosis they might have, isolation from being off work and alone at such a stressful time and unease about what the future might hold were common concerns. With the help of men who have lived through testicular cancer and an international panel of experts, we designed

15 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

and created a digital resource called Nuts & Bolts focused on supporting men beyond their diagnosis and communicated in a way that resonates with men. It allows experts as well as hear from and talk to men who have lived experience of the disease.

In the UK, the Talk to a Guide function provides the opportunity for any man going through testicular cancer to be connected to someone who has lived through the disease for support.

To date, Nuts & Bolts has received over 77,000 visitors and most feedback from users has been positive. We will continue to build on this success as we aim to create the go-to global platform to support men facing a diagnosis of testicular cancer along with their family, supporters and loved ones. More information can be found at:

that were successful during two years of piloting and the delivery of the project and associated activities to determine whether they can be scaled for a further three years.

VETERANS AND FIRST RESPONDERS MENTAL HEALTH GRANT PROGRAMME

In August 2021, Movember announced that 15 projects from around the globe would receive funding through the Veterans and First Responders Mental Health Grant responders, as well as their families, is a collaboration between Movember and The Distinguished Gentleman’s Ride with additional funding from Gillette in the UK.

nutsandbolts.movember.com

SOCIAL INNOVATORS CHALLENGE

Launched in 2016, the goal of the Social Innovators Challenge (SIC) project, was to improve our understanding about what engages men to build strong social connections, particularly those who are at risk of becoming socially isolated. Following an extensive review process, 13 projects were approved for funding. After a successful two-year pilot, four projects in the UK were approved for scaling or further funding.

The Scottish Association for Mental Health commenced a three-year scaling of their programme ‘The Changing Room’ across Scotland through the Scottish Professional Football League teams. The project brings together men in their middle years through their shared love of football.

restrictions and moved online to keep men engaged in the program. The team developed a ‘playbook’ for the ‘train the trainer’ component of the programme. The programme will continue to be evaluated to measure improvements in social connectedness as well as whether the programme can achieve the same outcomes in scaled form.

The other three projects – Boxing Futures – ‘Brothers Through Boxing,’ Co-operative & Mutual Solutions Ltd. - ‘Ex-Cell 50+ and Food Nation – Men’s Pie Club are currently in a period of further project development and have been extended over the next six to 12 months. The project teams adapted their programmes to accommodate social distancing measures during the

The overall goal of this funding however remains the

military veterans are at increased risk of poor mental health and suicide.

Although many programmes that aim to support these groups already exist, a 2019 report commissioned by Movember found a lack of publicly available evidence showing the effectiveness of such programmes. Based on the report, Movember launched the Veterans and First Responders Mental Health Grant Programme in September 2020, with the aim of identifying promising mental health or suicide prevention programmes and collaborating with those projects to demonstrate their effectiveness through rigorous programme evaluation.

The three funded projects in the UK are:

• The Police Service of Northern Ireland’s Mental Wellbeing and Trauma Resilience Programme approach to embed a culture of prevention and early intervention among police in Northern Ireland, their families, and the communities they serve.

• The University of Leicester’s Resilient Senior Leaders Programme (RESLEAPS) , funded through the Gillette Partnership, is a prevention programme for police superintendents that expands on an earlier pilot of forces in England and Wales which fosters a trusting culture and creates a safe space to share concern.

• The University of York will be implementing and evaluating their Behavioural Activation for Low mood and anxiety in Male NHS frontline workers (BALM) programme. The BALM Programme will utilise Behavioural Activation as an early mental health intervention for male NHS frontline workers. This programme is supported through the Gillette Partnership.

16 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

DIGITAL SOCIAL CONNECTIONS CHALLENGE

In August 2021, Movember announced that 11 men’s health projects across Australia, Canada, the UK, and Ireland are to receive funding over the next two years though Movember’s Digital Social Connections Challenge (DSCC) which was set up as one of a few Movember responses to mitigate the effects of the global pandemic. This initiative was designed as a codevelopment programme focused on ideas that would strengthen the social connections of men who were struggling with isolation and anxiety, in the wake of COVID-19 lockdowns.

In the UK, four projects are being co-developed with Movember. Those that show promise may receive additional funding to implement, test and evaluate their projects in their respective communities.

Gamers vs Depression

This project uses online gaming as a vehicle for developing depression literacy and better social connections in adolescent males. Delivered by That Awfully Good Community Interest Company based in Colchester, Essex, the aim is for ‘gaming teams’ to act as a social/peer-support group where young men can openly discuss challenges outside of their immediate network in a safe and supportive manner.

Fathers Network Scotland Wellbeing app

Fathers Network Scotland, Shared Parenting Scotland and Held in our Hearts directly support men during some of the most stressful times in their lives such as those coping with family breakdown or with the loss of a child.

Their aim with this project, supported by Mr Porter’s Health in Mind initiative, is to develop a wellbeing app for men in Scotland that would enable them to support many more fathers. The app will allow those in need of services to access help for themselves and also provide resources for those who are worried about a male friend or relative, directing them as quickly and easily as possible to the services nearest to them.

Maate!

This is a digital platform to help young men (particularly those not in school, employment or those who are working remotely) to maintain social connections by assisting in the organisation of free virtual group activities (such as trivia, virtual escape rooms or card games) and taking the hard work out of catching up.

Chai in the City

This project is aimed at breaking down the stigma surrounding mental health for men and boys from Punjabi communities in the UK. Through facilitated discussion groups, the project gets Punjabi men talking about their mental health, life challenges, and things they may not feel comfortable speaking about freely with their family or friends. Launched by an organisation called Taraki, the goal is to create a model that can be scaled globally and eventually tailored to communities disabled Punjabi men.

DISTINGUISHED GENTLEMAN’S RIDE SOCIAL CONNECTIONS CHALLENGE

In May 2021, Movember announced that nine projects had been granted funding through the Distinguished Gentleman’s Ride Social Connections Challenge, focused upon improving the mental health and wellbeing of male motorcyclists. The aim of the challenge was to support ideas that strengthen social connections and build relationships to improve the social connectedness, life satisfaction and mental wellbeing of motorcycle riders.

In the UK three projects, have received funding:

• Quay Rider is a mentorship initiative based at a motorcycle workshop in Poole, Dorset. The project aims to connect older men with young men who are living in care. Participants will learn how to build and modify a motorcycle, on which the younger riders will undertake a series of off-road challenges under the guidance of their mentors.

• is an online platform for middle-

• aged riders, looking for places to socially interact with others. The team from Havant, Hampshire, will use social media to inform the community, many of whom are men who are hard to reach, about upcoming events to participate in and report on past events.

• encourages motorcyclists to

• socialise with each other, strengthening existing relationships or developing new ones. Based in Bournemouth, Dorset, the team plans to use a ‘health by stealth’ approach, providing mental health services and mental health literacy alongside practical bike maintenance tips.

17 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

AHEAD OF THE GAME

Movember’s Ahead of The Game (AoTG) is a series of increase mental health literacy and boost resilience in adolescent athletes who take part. The evidence-based programme is aimed at adolescents aged between 12-18 and delivered through community sports clubs. During the one-hour workshops, participants learn how to spot the signs of anxiety, depression and low mood in themselves and others. In separate workshops, their parents and sports coaches learn how to distinguish between potential mental health problems and normal teenage behaviour.

The programme was tested by researchers at the University of Wollongong in Australia on 350 boys aged between 12 and 18 across different sports including football, rugby league and swimming, over a season-long period. Teenagers who took part in the study – the biggest of its kind in the world – demonstrated a better understanding of what mental health is, had greater intentions to help others with seeking help themselves if they needed to.

World Cup 2021 which will take place in November 2022, Movember is working with delivery partner Rugby

8,000 teenage rugby league players, their parents, and sports coaches. Face-to-face workshops, which are delivered by current and former professional athletes, resumed in April 2021, following the lifting of lockdown restrictions in the north of England and as of May 2022, approximately 273 sessions had been delivered – equating to around 4,000 athletes, parents and coaches.

Following a successful pilot of the programme in football with academy scholars at Albion in the Community is working with Fulham FC Foundation to deliver AoTG workshops to 1,500 children across south-west London and Surrey through the Player Pathway Programme, Girls Development Centre, Premier League Kicks, Premier League Inspires and Pan Disability Football Clubs.

Thanks to funding provided by Public Health England in 2022, the programme has been piloted in school sport settings in St Helens in Merseyside, England. The pilot evaluation will inform Movember’s approach going forward. Movember has ambitious plans to engage more delivery partners across sporting codes and take AoTG to scale within the UK market to improve the mental health literacy and resilience of young men through community sport.

18 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

FINANCIAL REVIEW

Movember Europe delivered another strong result in the year ended 30 April 2022, bringing in total income of £19.6 million. While this is lower than the £26.9m we received in FY20/21, when we were able to focus on virtual engagement with an especially captive audience during the Covid-19 pandemic, it is up on the £18m received in FY19/20, and so continues our general upward trend. This total was primarily driven by donation income from our community of Mo Bros and Sisters – through nearly 137,000 registered participants for our 2021 Movember campaign (down from 170,000 in 2020, but up from 130,000 in 2019).

Furthermore, revenue from sources outside the annual Corporate Partners increased to £2.0m (£1.4m in

2020/21), and we saw further revenue from our Major Gifts function (£87k, compared to £131k in 2020/21). The sixth year of the partnership with the Distinguished Gentleman’s Ride generated revenue of £1.3 million, Distinguished Gentleman’s Drive pilot event.

The organisation’s programmatic activity continues to produce outstanding outcomes for men’s health. Movember Europe spent £8.0 million on programme expenditure during the year (£7.7 million in 2020/21) resulting in a net movement in funds of £7.4 million (£15.7 million in 2020/21).

The organisation has set ambitious targets to grow both our core campaign as well as year-round income streams, and remains committed to funding exciting and innovative projects across the UK and Europe.

19 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

PRINCIPAL RISKS AND UNCERTAINTIES

standardised likelihood and consequence scales which align with Movember’s risk appetite statement.

There are three artefacts used together in managing risk at Movember:

A risk appetite statement, developed by the Trustees, which sets out the Board’s appetite for the amount and type of risk Movember is willing to accept, retain or tolerate in pursuit of organisational mission and strategy.

A risk management plan, setting out the methodology and processes put in place by management to ensure across Movember. This plan includes Movember’s risk matrix, which provides a set of consistent analyses and evaluation categories to assess the severity of

and management’s analysis of the likelihood and consequences of those risks, along with the mitigations (or treatments) implemented and the residual likelihood and consequences of those risks.

The risk register is kept up to date by management and reviewed periodically by the Trustees. Risks given a commentary and have been included in the table below alongside a summary of the mitigation plan.

Risk	Risk	Risk		Rating Mitigation Plan	Rating Mitigation Plan	Rating Mitigation Plan	Rating Mitigation Plan	Rating Mitigation Plan
Dominant news and/or external				HIGH Movember has				proactively sought					ways to use our brand and voice
events distract attention from the
Movember campaign (e.g. COVID- 19,				disruptions since 2020.
political unrest, or a terrorism event)
impacts negatively on campaign				Marketing plans are developed to include contingency													plans for unforeseen
fundraising revenue.				events (and lockdown scenarios)								that may occur between						late September and
				early December for each market								the Movember Campaign runs in.
				The Board has a policy to reserve funds annually to ensure operational costs can
				be met for			9 – 12 months if forecast						fundraising targets aren’t met for any reason.
A	data breach (unauthorised use			HIGH An annual cyber security audit is								undertaken in relation to Movember’s core
of, or access to personal data				fundraising platform.
collected, stored by (or on behalf of)
Movember) could occur.				Movember undertakes work to continually assess the effectiveness and
				enhance internal training and							support provided for staff working								on activities
				that are likely to present particular privacy										risks (programs involving personal
				health information, fundraising, HR etc).
				Access controls				included in core software applications, Single Sign-on is used for
				access on most				platforms, and			reporting enabled to alert of credential breach.
				Staff off-boarding processes include removal of system log-in details																	to
				Movember systems and software.
				Movember funded programs that involve the collection, storage and use of privacy and data security processes are included in study protocols.
				HIGH Management has increased the number of all staff town hall meetings, Q&A
negatively impact on organisational
culture, employee effectiveness and				ensure multiple channels to respond to employee concerns and needs.
require increased recruitment effort
and cost.				Talent mapping				and succession planning is actively undertaken to ensure
				continuity			of organisational work and provide								high impact and high potential
				employees with				opportunities to work on activities or towards alternative roles of
				interest to them and value to Movember.
				In some areas of particular skills demand and market-shortages (e.g. tech),
				retention strategies have been							implemented			in relation to key roles.

20 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

RESERVES POLICY AND GOING CONCERN

The unrestricted funds balance for the year ending 30 April 2022 was £41.4 million. Of this balance, programmes while the balance of £6.5m is retained for general purposes. As the majority of Movember Europe’s revenue is currently derived from one annual campaign, conservative approach to risk management; the Board approved Policy requires an accumulation of a general reserves of between 9 and 12 months’ coverage of costs.

The Movember Europe Trustees have elected to maintain a reserves balances equivalent to approximately 10 months of expenditure, or £6.5m, which falls within the Board approved policy.

As a result, no further action is required prior to the review of reserves that will take place at the end of the

On March 11, 2020, the Covid-19 outbreak was declared a pandemic by the World Health Organisation. Since been impacting the global economic environment due to government-imposed lockdowns and social distancing requirements. Although the pandemic has had an impact of the operations and activities of Movember Europe, the organisation has been able to maintain a strong the organisation will remain a going concern.

Designated (and restricted) funds have been allocated to the following programmes, and trustees currently expect the majority of this balance to be committed as set out below.

Programme	Within 1 year	Between	Later than	Total (million)
		1 and 3 years	3 years
PROSTATE AND TESTICULAR CANCER BIOMEDICAL RESEARCH	1.1	3.9	0.1	5.1
PROSTATE AND TESTICULAR CANCER SURVIVORSHIP AND HEALTH OUTCOMES	1.8	12.8	0.9	15.5
MENTAL HEALTH & SUICIDE PREVENTION	3.9	9.1	0.1	13.1
MEN’S HEALTH PROGRAMMES AND HEALTH PROMOTION	1.2	1.0	-	2.2
	8.0	26.8	1.1	35.9

Funds dedicated to prostate and testicular cancer Biomedical research continue to support existing multi-year projects under Movember’s national and global programmes.

Funds assigned to Prostate and Testicular Cancer Survivorship and Health Outcomes will support ongoing clinical quality and survivorship projects such as the IRONMAN Registry, TrueNTH Global Registry and Nuts and Bolts into years 5, 6 and 7. The Global Cancer Real World Evidence Network (RWE) was launched and seeks to unify existing Movember funded programmes across the globe and create a network that can support accelerated impact across biomedical research, clinical quality and survivorship. We will continue with and expand our clinical partnerships over the coming years.

Funding for Mental Health and Suicide Prevention programmes is being utilised across a broad range of prevention and early intervention programmes. Existing projects will continue to work with their contracted partners through to completion. New projects will work closely with new partners to achieve their programme goals and utilise existing partner expertise as and when applicable.

Funding for Men’s Health Promotion focuses on the continuation and expansion of an existing programme of mass media behaviour change. In the UK our programme Based on the positive evaluation results from our initial pilot, we expect to scale and grow this work over the next two years. Movember also intends to develop and launch in Ireland to produce a documentary targeting health behaviour change.

21 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

FUNDRAISING POLICY

Fundraising Practices

Movember aims to ensure that all of our fundraising activities are done in an open, honest and compliant manner wherever we operate. In the UK we are a member of the Chartered Institute of Fundraising and voluntarily subscribe to the Fundraising Regulator. This regulator has been responsible, since July 2016, for overseeing an independent and voluntary system of regulation of fundraising by charities. We set ourselves standards that aim to meet or exceed their Code of Fundraising Practice.

Fundraising Performance

After the exceptional results of the Movember Campaign our Fundraising revenue is back at its pre-pandemic level. The number of Mo Bros and Mo Sisters taking part into our Movember campaign and raising funds to support men’s health in our 2021 campaign is up on 2019, following the growth trend we’ve seen in the last 5 years. This performance is attributed to a mixture of carefully planned investment in media to raise awareness of Movember’s brand and campaign; efforts to retain and keep our supporters engaged across the year; and a focus on helping our Campaign participants raise vital funds for men’s health.

peer to peer campaign in order to secure a sustainable long-term source of revenue. In 2021 we have trialled different models of peer to peer physical challenge events to attract new supporters or offer to our existing supporters other ways to support our work throughout the year. These trials saw a good level of engagement with a decent return on investment and we are working at scaling some of them in the next few years.

Supporters’ Data

Movember maintains a global GDPR compliant commitment to being respectful, fair and transparent with Mo Bros, Mo Sisters, employees, partners and authorities about how we collect, use and safeguard personal information.

Working with Third Parties

Our Mo Community is key to Movember’s ongoing success, and is at the heart of everything we do, therefore we aim to offer a remarkable experience to every single person that gets in touch with us or gets involved with the campaign in any way. The majority of our fundraising is carried out by our committed Mo Bros and Sisters, growing a moustache, running 60km as a Move challenge, hosting an event, or undertaking their own challenges and raising money whilst doing so from their friends, families and local businesses. Movember does not use professional fundraisers to carry out its fundraising activities.

Movember has a number of arrangements in place with Commercial Participators, including our Corporate Partners. Where these arrangements exist, we ensure that contracts are in place that include a commitment from the Commercial Participator that they will comply with the Fundraising Code of Practice. We maintain a system of monitoring compliance with these requirements, and ensure that any complaints from the public are fed back to in place for the running of the Distinguished Gentleman’s Ride and Distinguished Gentleman’s Drive, whereby the Participator organises the events and collects donations on our behalf, in return for a fee. This agreement involves a commitment to comply with the Fundraising Code of Practice, and allows for monitoring and dissemination of any complaints received.

22 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

Complaints

complaints, all of which were satisfactorily addressed and resolved locally. There were no complaints referred from the Fundraising Regulator. We always work to resolve all complaints in a professional and timely manner. We review our Complaints Policy on an annual basis to ensure that we are adopting best practice.

Protecting Vulnerable People

Our current fundraising model is primarily based on peer-to-peer donations, and our activities are designed to ensure that no one is put under pressure to donate to us. We are broadening our fundraising strategy and we will continue to review all our safeguarding mechanisms and policies to ensure that we are adopting best practice to protect vulnerable people in all our activities.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Movember Europe is a company limited by guarantee, incorporated on 07/06/2010 and registered as a charity on 10/09/2010. The company was established under a memorandum of association which established the objects and powers of the charitable company and is governed under its articles of association (“Articles”). The single member of Movember Europe is The Movember Group Pty Ltd as trustee for the Movember Foundation Trust (an Australian charitable organisation).

The Articles provide that the business of Movember Europe is to be managed by the Board of Trustees (“Board”). During the 2021/22 year the Board was advised by the following sub- committees:

• Finance, Risk and Audit Committee

• People & Culture Committee

PLANS FOR THE FUTURE

Our ambition for the next three years remains to continue to place our cause and our supporters at the heart of all our fundraising and marketing activities, increasing our focus on mental health and suicide prevention, and to expand the ways in which the public can interact and campaign in November. As part of this expansion of fundraising activities, we will continue to offer to our community the possibility to support Movember at other times of the year through their participation in different challenge events.

We are in the process of developing a new impact strategy, which will inform and guide Movember’s programme investments during 2023 and beyond.

Movember will continue to invest in Prostate and Testicular Cancer biomedical research with our existing partners and Prostate Cancer UK. We will continue to expand our Prostate and Testicular Cancer Survivorship and Clinical Quality work through existing and new partnerships.

With an increased focus on mental health and suicide prevention, Movember will leverage the results of evidence building efforts over the past decade to continue to develop and implement new programmes addressing key at-risk populations of men. Movember’s Mental Health programmes are funded over multiple years, enabling the achievement of sustained growth, reach and impact, through an evidence-based behaviour change framework.

• Programs Strategy & Investment Committee

• Global Prostate Cancer Outcomes Committee

• Global Men’s Health Advisory Committee

• Ad-hoc committees are appointed by the Board where necessary

The Board and its committees are governed by the charters and policies set out in the Movember Governance Policies, including policies in relation to

All Trustees give their time voluntarily and receive no the charity are set out in note 7 to the accounts.

year. The Finance, Risk and Audit Committee met four times, the People & Culture Committee met twice, the Programs Strategy & Investment Committee met three times, the Global Men’s Health Advisory Committee three times and the Global Prostate Cancer Outcomes Committee met twice.

The Board is accountable for Movember’s performance; Trustees consider every Mo Bro, Mo Sister, donor, partner and the men that Movember serves as key stakeholders to whom that accountability is owed.

23 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

The Board’s primary functions include:

• Providing reporting, transparency and accountability to Movember’s stakeholders

• Setting Movember’s strategic direction, and monitoring and supporting management’s delivery of Movember’s strategic plan

• Selecting, appointing and managing the performance of the CEO

• Movember’s risk management practices

• Monitoring Movember’s compliance with legal and reporting

APPOINTMENT AND TRAINING OF TRUSTEES

New Trustees are appointed by the member of Movember Europe on recommendation from the Board. Selection and interviewing for new Trustees is undertaken by an ad-hoc committee of the Board. The primary consideration when selecting new Trustees is to ensure an appropriate balance of skills and experience. Training and induction of Trustees is tailored to the needs of

RELATED PARTIES AND RELATIONSHIPS WITH OTHER ORGANISATIONS

The Movember Group Pty Ltd as trustee for the Movember Foundation Trust (Movember Europe’s parent), as well as being a registered charity in its own right in Australia, is also the parent of the Movember registered charity organisations in the US (Movember Foundation (US)) and Canada (Movember Canada). The board of Movember Europe has majority control over Movember Foundation e.V. and this entity is therefore treated as a subsidiary entity for consolidation purposes. Each of Movember’s registered charities (in Australia, UK, US, Canada, Germany and New Zealand) are all managed by staff and management based in the relevant country or nearby, but they share central services such Melbourne, Australia.

Various Trustees that sit on the Board of Movember Europe also sit on the boards of The Movember Group Pty Ltd, Movember Canada, Movember Foundation (US), Movember Foundation e.V. and Movember Foundation NZ.

Movember Europe has a trading subsidiary, Movember Europe Trading Limited. The trading subsidiary was formed in 2011.

REMUNERATION POLICY FOR KEY MANAGEMENT PERSONNEL

Movember utilises the Korn Ferry HayGroup data review for all salaries including in the United Kingdom, and to provide ongoing market related information. Movember undertakes an annual review of the salary of all staff, including key management personnel, and this is benchmarked against an annualised refresh of market data provided by the Korn Ferry HayGroup. We use the Median (mid point), Top 25% and Top 10% as our key comparison points within the benchmark range to guide the salaries we offer our employees are fair and in line

POLICY FOR EMPLOYMENT OF DISABLED PERSONS

Movember’s Workplace Behaviours Policy clearly states that we will abide by all laws in relations to the employment of disabled persons and the policy forbids any discrimination on the grounds of a disability. Any employee found to be discriminating in line with any of the areas named in the above policy, would be subject to formal performance management, which depending on the seriousness may include termination of employment. We use recruitment methods that encourage applications from people with diverse backgrounds and abilities, ensuring all applicants are treated fairly.

EMPLOYEE INFORMATION

All UK based staff have the opportunity to be part of a Pension Scheme. All staff are kept fully informed on the program and any pension changes announced by the government are communicated to staff through a followed by an opportunity provided to all staff for a oneon-one consultation.

We have developed an internal communications strategy and schedule to provide information to staff and seek their feedback. Initiatives to inform staff include updating the intranet with organisational news, information and policies, and providing updates on all areas of the organisation during regular emails from the leadership team and all-staff town halls. There are also weekly fortnightly team meetings.

24 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE TRUSTEES’ ANNUAL REPORT

Staff are frequently encouraged to ask questions and provide feedback informally through their manager or HR team. Formal channels for staff consultation include an annual employee engagement survey and pulse surveys. These surveys cover all areas of the organisation, for example engagement, leadership and development. In 2020 we also conducted surveys on Staff Wellbeing and Diversity, Equity and Inclusion. We report the results back to staff and they have the opportunity to discuss the results within their team meetings. Following this, we create local and global action groups to implement agreed actions. In 2022 we will be conducting an externally managed Psychological Safety Survey to proactively address psychological safety in the workplace. Staff are also provided with the opportunity for an ‘ask me anything’ question and answer session with the leadership team during town halls and when the leadership

followed, subject to any material departures disclosed

• concern basis unless it is inappropriate to presume that the charity will continue in operation.

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable charitable company and enable them to ensure that the 2006. They are also responsible for safeguarding the assets of the charitable company and group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the Trustees are aware:

Each year we recommend that staff review the organisation’s annual report, which provides information and relevant data regarding the company accounts and

All of this is underpinned by a global Human Resources team who are available for any member of the team to assistance program available 24/7.

STATEMENT OF RESPONSIBILITIES OF THE TRUSTEES

The Trustees (who are also directors of Movember Europe for the purposes of company law) are responsible for preparing the trustees’ annual report including accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

fair view of the state of affairs of the charitable company and group and of the incoming resources and application of resources, including the income and expenditure, of the charitable company or group for that period. In preparing

• Select suitable accounting policies and then apply them consistently.

• Observe the methods and principles in the Charities SORP.

• Make judgements and estimates that are reasonable and prudent.

• State whether applicable UK Accounting Standards and statements of recommended practice have been

• There is no relevant audit information of which the charitable company’s auditor is unaware.

• The trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.

The Trustees are responsible for the maintenance and included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and legislation in other jurisdictions.

Members of the charity guarantee to contribute an amount not exceeding £1 to the assets of the charity in the event of winding up. The total number of such guarantees at 30 April 2021 was 10 (2020: 8). The trustees are members of the charity but this entitles them only to voting rights. The trustees have no

AUDITOR

Sayer Vincent LLP was re-appointed as the charitable company’s auditor during the year and has expressed its willingness to continue in that capacity.

The Trustees’ annual report which includes the strategic report has been approved by the Trustees on 8 September 2022 and signed on their behalf by

Nicholas Reece Chairperson

25 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

INDEPENDENT AUDITOR'S REPORT

MOVEMBER EUROPE INDEPENDENT AUDITOR’S REPORT

OPINION

Europe (the ‘parent charitable company’) and its subsidiaries (the ‘group’) for the year ended 30 April 2022 activities, the group and parent charitable company

framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

• Give a true and fair view of the state of the group’s and of the parent charitable company’s affairs as at 30 April 2022 and of the group’s incoming resources and application of resources, including its income and expenditure, for the year then ended

• Have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice

• Have been prepared in accordance with the requirements of the Companies Act 2006, the Charities and Trustee Investment (Scotland) Act 2005 and regulations 6 and 8 of the Charities Accounts (Scotland) Regulation 2006 (as amended)

or conditions that, individually or collectively, may cast as a going concern for a period of at least twelve months

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

OTHER INFORMATION

The other information comprises the information included in the trustees’ annual report, including the our auditor’s report thereon. The trustees are responsible for the other information contained within the annual cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

BASIS FOR OPINION

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit independent of the group in accordance with the ethical statements in the UK, including the FRC’s Ethical Standard, in accordance with these requirements. We believe that appropriate to provide a basis for our opinion.

OPINIONS ON OTHER MATTERS PRESCRIBED BY THE COMPANIES ACT 2006

In our opinion, based on the work undertaken in the course of the audit:

• The information given in the trustees’ annual report,

• The trustees’ annual report, including the strategic report, has been prepared in accordance with applicable legal requirements

CONCLUSIONS RELATING TO GOING CONCERN

MATTERS ON WHICH WE ARE REQUIRED TO REPORT BY EXCEPTION

that the trustees’ use of the going concern basis of is appropriate.

Based on the work we have performed, we have not

In the light of the knowledge and understanding of the group and the parent charitable company and its environment obtained in the course of the audit, we have annual report, including the strategic report.

27 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE INDEPENDENT AUDITOR’S REPORT

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 and Charities Accounts (Scotland) Regulations 2006 (as amended) requires us to report to you if, in our opinion:

• Adequate accounting records have not been kept by the parent charitable company, or returns adequate for our audit have not been received from branches not visited by us; or

• are not in agreement with the accounting records and returns; or

• Certain disclosures of trustees’ remuneration

• We have not received all the information and explanations we require for our audit

the aggregate, they could reasonably be expected to

Irregularities, including fraud, are instances of noncompliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud are set out below.

CAPABILITY OF THE AUDIT IN DETECTING IRREGULARITIES

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following:

RESPONSIBILITIES OF TRUSTEES

As explained more fully in the statement of trustees’ responsibilities set out in the trustees’ annual report, the trustees (who are also the directors of the parent charitable company for the purposes of company law) are responsible internal control as the trustees determine is necessary to from material misstatement, whether due to fraud or error.

responsible for assessing the group’s and the parent charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the group or the parent charitable company or to cease operations, or have no realistic alternative but to do so.

AUDITOR’S RESPONSIBILITIES FOR THE AUDIT OF THE FINANCIAL STATEMENTS

We have been appointed as auditor under section 44(1) (c) of the Charities and Trustee Investment (Scotland) Act 2005 and under the Companies Act 2006 and report in accordance with regulations made under those Acts.

Our objectives are to obtain reasonable assurance about material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in

• and risk committee, which included obtaining and reviewing supporting documentation, concerning the group’s policies and procedures relating to:

• i. Identifying, evaluating, and complying with laws and regulations and whether they were aware of any instances of non-compliance;

• ii. Detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected, or alleged fraud;

• iii. The internal controls established to mitigate risks related to fraud or non-compliance with laws and regulations.

• We inspected the minutes of meetings of those charged with governance.

• We obtained an understanding of the legal and regulatory framework that the group operates in, focusing on those laws and regulations that had a a fundamental effect on the operations of the group from our professional and sector experience.

• We communicated applicable laws and regulations throughout the audit team and remained alert to any indications of non-compliance throughout the audit.

• We reviewed any reports made to regulators.

• tested these to supporting documentation to assess compliance with applicable laws and regulations.

• We performed analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud.

28 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE INDEPENDENT AUDITOR’S REPORT

In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments, assessed whether the judgements made in making accounting estimates are indicative of a potential bias and tested outside the normal course of business.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: frc.org.uk/auditorsresponsibilities.

This description forms part of our auditor’s report.

USE OF OUR REPORT

This report is made solely to the charitable company’s members as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and section 44(1) (c) of the Charities and Trustee Investment (Scotland) Act 2005. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Noelia Serrano

(Senior statutory auditor) 23 September 2022

for and on behalf of Sayer Vincent LLP, Statutory Auditor Invicta House, 108-114 Golden Lane, LONDON, EC1Y 0TL

Sayer Vincent LLP is eligible to act as auditor in terms of section 1212 of the Companies Act 2006.

29 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE FINANCIALS

CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES

INCORPORATING AN INCOME AND EXPENDITURE ACCOUNT

For the year ended 30 April 2022

Notes Unrestricted (£)	Restricted (£) 2022 Total (£) Unrestricted (£) Restricted (£) 2021 Total (£)
INCOME FROM:
DONATIONS AND LEGACIES 2 17,445,404	- 17,445,404 25,238,674 - 25,238,674
OTHER TRADING AND CHARITABLE ACTIVITIES 3 1,261,420	857,552 2,118,972 991,422 564,356 1,555,778
INVESTMENTS 58,558	- 58,558 56,598 - 56,598
TOTAL INCOME 18,765,382	857,552 19,622,934 26,286,694 564,356 26,851,050
EXPENDITURE ON:
RAISING FUNDS 4 3,469,678	- 3,469,678 3,211,913 - 3,211,913
CHARITABLE ACTIVITIES
PROGRAMME EXPENDITURE 4 7,809,849	446,432 8,256,281 7,334,316 368,323 7,702,639
TOTAL EXPENDITURE 11,279,527	446,432 11,725,959 10,546,229 368,323 10,914,552
NET INCOME FOR THE YEAR 6 7,485,855	411,120 7,896,975 15,740,465 196,033 15,936,499
TRANSFERS BETWEEN FUNDS -	- - (48,164) 48,164 -
NET INCOME BEFORE OTHER RECOGNISED GAINS AND LOSSES 7,485,855	411,120 7,896,975 15,692,301 244,197 15,936,499
OTHER (LOSSES) (568,637)	- (568,637) (252,667) - (252,667)
NET MOVEMENT IN FUNDS 6,917,218	411,120 7,328,338 15,439,634 244,197 15,683,831
RECONCILIATION OF FUNDS:
TOTAL FUNDS BROUGHT FORWARD 34,480,018	546,312 35,026,330 19,040,384 302,115 19,342,499
TOTAL FUNDS CARRIED FORWARD 41,397,236	957,432 42,354,668 34,480,018 546,312 35,026,330

All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. All income, expenditure and gains in the prior year relate to unrestricted funds. Movements in funds are disclosed in Note 19 to

30 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE FINANCIALS

BALANCE SHEETS

as at 30 April 2022

				The Group		The Charity
		Notes	2022 (£)	2021 (£)	2022 (£)	2021 (£)
	FIXED ASSETS:
	TANGIBLE ASSETS	11	27,400	118,398	27,400	118,398
	INVESTMENTS	12	-	2,500,000	1	2,500,001
			27,400	2,618,398	27,401	2,618,399
	CURRENT ASSETS:
	DEBTORS	15	2,134,867	3,071,568	3,247,812	3,353,022
	SHORT TERM DEPOSITS		17,664,868	11,934,949	17,664,868	11,934,949
	CASH AT BANK AND IN HAND		31,920,460	30,128,838	28,545,361	27,783,029
			51,720,195	45,135,356	49,458,042	43,071,000
	LIABILITIES:
	CREDITORS: AMOUNTS FALLING DUE
	WITHIN ONE YEAR	16	(9,199,801)	(12,656,498)	(9,131,699)	(12,639,038)
	NET CURRENT ASSETS		42,520,394	32,478,858	40,326,343	30,431,962
	TOTAL ASSETS LESS CURRENT
	LIABILITIES		42,547,793	35,097,255	40,353,744	33,050,361
	CREDITORS: AMOUNTS FALLING DUE
	AFTER ONE YEAR	17	(193,126)	(70,926)	(193,126)	(70,926)
	TOTAL NET ASSETS		42,354,668	35,026,330	40,160,618	32,979,435
	FUNDS:	19a
	RESTRICTED INCOME FUNDS		957,432	546,312	957,432	546,312
	UNRESTRICTED INCOME FUNDS:
	DESIGNATED FUNDS		34,921,236	27,486,463	33,292,238	25,773,575
	GENERAL FUNDS		6,476,000	6,993,555	5,910,948	6,659,548
	TOTAL UNRESTRICTED FUNDS		41,397,236	34,480,018	39,203,186	32,433,123
	TOTAL FUNDS		42,354,668	35,026,330	40,160,618	32,979,435

Approved by the trustees on 8 September 2022 and signed on their behalf by

Nicholas Reece Chairperson

31 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE FINANCIALS

CONSOLIDATED STATEMENT OF CASH FLOWS

For the year ended 30 April 2022

	Notes	2022 (£)	2021 (£)
	CASH FLOWS FROM OPERATING ACTIVITIES
	NET INCOME FOR THE REPORTING PERIOD
	(AS PER THE STATEMENT OF FINANCIAL ACTIVITIES)	7,896,975	15,936,499
	DEPRECIATION CHARGES	97,740	104,050
	DIVIDENDS, INTEREST AND RENT FROM INVESTMENTS	(58,558)	(56,598)
	DECREASE/(INCREASE) IN DEBTORS	936,701	(1,213,722)
	(DECREASE) IN CREDITORS	(3,334,497)	(783,552)
	NET CASH PROVIDED BY OPERATING ACTIVITIES	5,538,361	13,986,677
	CASH FLOWS FROM INVESTING ACTIVITIES:
	DIVIDENDS, INTEREST AND RENTS FROM INVESTMENTS	58,558	56,598
	PURCHASE OF FIXED ASSETS	(6,789)	(12,723)
	PROCEEDS FROM SALE OF INVESTMENTS	2,500,000	-
	PURCHASE OF INVESTMENTS	-	(2,500,000)
	NET CASH PROVIDED BY/(USED IN) INVESTING ACTIVITIES	2,551,769	(2,456,125)
	CASH FLOWS FROM FINANCING ACTIVITIES:
	AMOUNTS (INVESTED) IN SHORT TERM DEPOSITS	(5,729,919)	(6,020,498)
	NET CASH (USED IN) FINANCING ACTIVITIES	(5,729,919)	(6,020,498)
	CHANGE IN CASH AND CASH EQUIVALENTS IN THE YEAR	2,360,211	5,510,053
	CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR	30,128,838	24,866,331
	CHANGE IN CASH AND CASH EQUIVALENTS DUE TO EXCHANGE RATE
	MOVEMENTS	(568,589)	(247,546)
	CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR	31,920,460	30,128,838

Analysis of cash and cash	equivalents and of net debt
	At 1 May 2021 (£)		Other non-cash	At 30 April 2022
			changes (£)	(£)
CASH AT BANK AND IN HAND	30,128,838	2,360,211	(568,589)	31,920,460
TOTAL CASH AND CASH EQUIVALENTS	30,128,838	2,360,211	(568,589)	31,920,460

32 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

NOTES TO THE FINANCIAL STATEMENTS MOVEMBER EUROPE FOR THE YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

1 ACCOUNTING POLICIES

(a) Statutory information

Movember Europe is a charitable company limited by guarantee and is incorporated in England and Wales. Rosebery Avenue, London, England, EC1R 4RP.

Movember Europe is an incorporated charity registered with the Charity Commission for England and Wales, the Regulator Ireland.

accounting policy below.

The trustees do not consider that there are any sources of estimation uncertainty at the reporting date that have carrying amounts of assets and liabilities within the next reporting period.

(c)

under FRS 102.

(d) Going concern

business is Gensurco House, 52 - 54 Rosebery Avenue, London, England, EC1R 4RP.

(b) Basis of preparation

with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) - (Charities SORP FRS 102), The Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

the charity and its wholly-owned subsidiaries Movember Europe Trading Limited and Movember Foundation e.V. on a line by line basis. Transactions and balances between the charity and its subsidiaries have been Balances between the entities are disclosed in the notes of the charity’s balance sheet. A separate statement account, for the charity itself is not presented because the charity has taken advantage of the exemptions afforded by section 408 of the Companies Act 2006. As a summary of the result for the year is disclosed in the notes to the accounts.

Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy or note.

trustees have made a number of subjective judgements, estimates. Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The nature of the estimation means the actual outcomes could differ from those estimates. Any

The Trustees consider that, despite the global challenges resulting from the Covid-19 pandemic, there are no material uncertainties about the charity’s ability to continue as a going concern.

(e) Income

Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the income have been met, it is probable that the income will be received and that the amount can be measured reliably.

Income received in advance of the provision of a recognition are met.

(f) Donations of gifts, services and facilities

Donated professional services and donated facilities are recognised as income when the charity has control over the item or received the service, any conditions associated with the donation have been met, the receipt measured reliably. In accordance with the Charities SORP (FRS 102), volunteer time is not recognised so refer to the trustees’ annual report for more information about their contribution.

On receipt, donated gifts, professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain services market; a corresponding amount is then recognised in expenditure in the period of receipt.

(g) Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably interest paid or payable by the bank.

34 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

1 ACCOUNTING POLICIES (CONTINUED)

(h) Fund accounting

Unrestricted funds are donations and other incoming resources received or generated for the charitable purposes.

laid down by the donor. Expenditure which meets these criteria is charged to the fund.

Designated funds are unrestricted funds earmarked by the trustees for particular purposes.

(i) Expenditure and irrecoverable VAT

Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably. Expenditure is

• Costs of raising funds relate to the costs incurred by the charity in inducing third parties to make voluntary contributions to it, as well as the cost of any activities with a fundraising purpose.

• Expenditure on charitable activities includes the costs of programme expenditure undertaken to further the purposes of the charity and their associated support costs.

Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.

(j) Grants payable

Grants payable are made to third parties in furtherance of the charity’s objects. Single or multi-year grants are accounted for when either the recipient has a reasonable expectation that they will receive a grant and the trustees have agreed to pay the grant without condition, or the recipient has a reasonable expectation that they will receive a grant and that any condition attaching to the grant is outside of the control of the charity.

Provisions for grants are made when the intention to make a grant has been communicated to the recipient but there is uncertainty about either the timing of the grant or the amount of grant payable.

(k) Allocation of support costs

Resources expended are allocated to the particular activity where the cost relates directly to that activity. However, the cost of overall direction and administration of each activity, comprising the salary and overhead costs of the central function, is apportioned on the following basis which are an estimate, based on staff time, of the amount attributable to each activity.

Support and governance costs are re-allocated to each of the activities on the following basis which is an estimate, based on staff time, of the amount attributable to each activity:

Cost of fundraising	30%
Programme expenditure	70%

Governance costs are the costs associated with the governance arrangements of the charity. These costs are associated with constitutional and statutory requirements and include any costs associated with the strategic management of the charity’s activities.

(l) Operating leases

Rental charges are charged on a straight line basis over the term of the lease.

(m)

Items of equipment are capitalised where the purchase price exceeds £1,000. Depreciation costs are allocated to activities on the basis of the use of the related assets in those activities. Assets are reviewed for impairment if circumstances indicate their carrying value may exceed their net realisable value and value in use. Major components are treated as a separate asset where they its useful life.

between the revalued amount and the historic cost of the asset will be shown as a revaluation reserve in the balance sheet.

Depreciation is provided at rates calculated to write down the cost of each asset to its estimated residual value over its expected useful life. The depreciation rates in use are as follows:

IT equipment	2.5 years
Leasehold Improvements	5 years

(n) Investments

Investments in subsidiaries are at cost.

Fixed asset investments include cash balances that are invested in term deposits with a maturity of longer than 12 months.

(o) Debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

35 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

1 ACCOUNTING POLICIES (CONTINUED)

(p) Short term deposits

Short term deposits includes cash balances that are invested in accounts with a maturity date of between 3 and 12 months.

(q) Cash at bank and in hand

Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

(r) Creditors and provisions

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

(t) Foreign exchange

Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the net incoming resources for the year.

(u) Pensions

scheme. The assets of the scheme are held separately from those of the charity in an independently administered fund. The pension cost charge represents contribution payable and the charity has no other liability under the scheme.

(s) Financial instruments

2 INCOME FROM DONATIONS AND LEGACIES

	Unrestricted (£)	2022 Total (£)	Unrestricted (£)	2021 Total (£)
DONATIONS AND LEGACIES	16,467,542	16,467,542	23,442,345	23,442,345
GIFT AID CLAIMED ON DONATIONS	977,862	977,862	1,796,329	1,796,329
	17,445,404	17,445,404	25,238,674	25,238,674

3 INCOME FROM OTHER TRADING AND CHARITABLE ACTIVITIES

	Unrestricted	Restricted	2022 Total	Unrestricted	Restricted	2021 Total
	(£)	(£)	(£)	(£)	(£)	(£)
SALE OF GOODS	25,280	-	25,280	(4,350)	-	(4,350)
CAMPAIGN PARTNER
CONTRIBUTIONS	1,210,022	857,552	2,067,574	970,139	564,356	1,534,495
OTHER	26,118	-	26,118	25,633	-	25,633
	1,261,420	857,552	2,118,972	991,422	564,356	1,555,778

36 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

4A ANALYSIS OF EXPENDITURE (CURRENT YEAR)

4A ANALYSIS OF EXPENDITURE (CURRENT YEAR)
Charitable activities Raising funds (£) Programme expenditure (£) Governance costs (£) Support costs (£)	2022 Total (£) 2021 Total (£)
STAFF COSTS (NOTE 7) 1,295,468 2,373,603 - 671,729	4,340,801 3,442,316
ADMINISTRATION 30,144 64,161 - 5,118	99,424 67,050
CAMPAIGN COSTS AND EVENTS 321,664 322,496 - 1,084	645,244 438,516
CONTRACTORS FEES 181,864 281,306 - 126,160	589,330 489,681
ENTERTAINMENT 1,557 3,469 - 3,820	8,845 3,693
BANK CHARGES 225,395 20,855 - 73,912	320,162 357,599
INSURANCE 13,005 24,315 - 19,809	57,129 43,150
LEGAL AND PROFESSIONAL 14,385 24,784 38,864 16,498	94,532 92,301
IT 78,880 137,635 - 105,781	322,296 198,493
MARKETING 803,804 846,386 - 55,462	1,705,651 1,849,867
DEPRECIATION - - - 97,740	97,740 104,050
TRAVEL 11,576 26,274 - 2,337	40,187 2,919
MEN'S HEALTH PARTNER DISTRIBUTIONS & PROGRAMME DELIVERY (NOTE 5) - 2,967,939 - -	2,967,939 3,480,415
WEBSITE DEVELOPMENT AND MANAGEMENT 31,706 53,924 - 28,938	114,569 88,742
BUILDING AND UTILITIES 36,577 101,029 - 184,504	322,110 255,759
3,046,026 7,248,178 38,864 1,392,891	11,725,959 10,914,552
SUPPORT COSTS 412,152 980,738 - (1,392,891)	- -
GOVERNANCE COSTS 11,500 27,365 (38,864) -	- -
TOTAL EXPENDITURE 2022 3,469,678 8,256,281 - -	11,725,959
TOTAL EXPENDITURE 2021 3,211,913 7,702,639 - -	10,914,552

Of the total expenditure, £11,279,527 was unrestricted (2021: £10,546,229) and £446,432 was restricted (2021: £368,323).

37 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

4B ANALYSIS OF EXPENDITURE (PRIOR YEAR)

	Charitable activities	Charitable activities
	Raising	Programme	Governance	Support	2021
	funds	expenditure	costs	costs	Total
	(£)	(£)	(£)	(£)	(£)
STAFF COSTS (NOTE 7)	1,219,399	1,766,148	-	456,769	3,442,316
ADMINISTRATION	30,170	56,484	-	(19,605)	67,050
CAMPAIGN COSTS AND EVENTS	219,196	219,248	-	73	438,516
CONTRACTORS FEES	153,197	270,145	-	66,340	489,681
ENTERTAINMENT	937	1,568	-	1,187	3,693
BANK CHARGES	295,540	24,252	-	37,806	357,599
INSURANCE	11,647	19,207	-	12,296	43,150
LEGAL AND PROFESSIONAL	16,211	24,446	38,548	13,096	92,301
IT	49,517	79,129	-	69,848	198,493
MARKETING	856,033	913,482	-	80,353	1,849,867
DEPRECIATION	-	-	-	104,050	104,050
TRAVEL	617	2,479	-	(176)	2,919
MEN'S HEALTH PARTNER DISTRIBUTIONS &
PROGRAMME DELIVERY (NOTE 5)	-	3,480,415	-	-	3,480,415
WEBSITE DEVELOPMENT AND MANAGEMENT	26,689	41,432	-	20,621	88,742
BUILDING AND UTILITIES	27,449	72,020	-	156,290	255,759
	2,906,601	6,970,455	38,548	998,948	10,914,552
SUPPORT COSTS	293,969	704,980	-	(998,948)	-
GOVERNANCE COSTS	11,344	27,204	(38,548)	-	-
TOTAL EXPENDITURE 2021	3,211,913	7,702,639	-	-	10,914,552

5 MEN’S HEALTH PARTNER DISTRIBUTIONS & PROGRAMME DELIVERY

	2022 (£)	2021 (£)
PROSTATE CANCER UK	317,833	602,315
OTHER EUROPEAN HEALTH PARTNERS	1,334,862	2,076,106
MOVEMBER GLOBAL PROGRAMMES	1,315,244	801,995
	2,967,939	3,480,415

Movember’s organisational strategy has led to a strengthened investment in Mental Health and Suicide Prevention. the UK and Europe.

38 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

6 NET INCOME FOR THE YEAR

This is stated after charging / (crediting):

	2022 (£)	2021 (£)
DEPRECIATION	97,740	104,050
OPERATING LEASE RENTALS:
PROPERTY	124,369	109,053
OTHER	829	829
AUDITOR'S REMUNERATION (EXCLUDING VAT):
AUDIT	19,500	18,550
OTHER SERVICES	2,100	2,000
FOREIGN EXCHANGE GAINS OR LOSSES	(568,637)	(252,667)

7 ANALYSIS OF STAFF COSTS, TRUSTEE REMUNERATION AND EXPENSES, AND THE COST OF KEY MANAGEMENT PERSONNEL

Staff costs were as follows:

	2022 (£)	2021 (£)
SALARIES AND WAGES	1,452,017	1,244,033
REDUNDANCY AND TERMINATION COSTS	6,095	43,364
SOCIAL SECURITY COSTS	158,416	133,181
EMPLOYER’S CONTRIBUTION TO DEFINED CONTRIBUTION PENSION SCHEMES	47,648	42,646
RECHARGED STAFF COSTS FROM PARENT ENTITY	2,659,445	1,965,659
OTHER FORMS OF EMPLOYEE BENEFITS	17,180	13,433
	4,340,801	3,442,316

Movember Foundation charges Movember Europe for its share of certain costs for central services. The services carried out centrally include website development, hosting and maintenance; campaign theme design and related

national insurance) during the year between:

		2022	(No.)	2021	(No.)
£60,000	- £69,999		3		4
£70,000	- £79,999		-		-
£80,000	- £89,999		-		-
£90,000	- £99,999		1		1

39 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

7 ANALYSIS OF STAFF COSTS, TRUSTEE REMUNERATION AND EXPENSES, AND THE COST OF KEY MANAGEMENT PERSONNEL (CONTINUED)

personnel were £171,219 (2021: £274,039).

Trustees’ expenses represents the payment or reimbursement of travel and subsistence costs incurred by members relating to attendance at meetings of the trustees. There were nil such costs (2021: £nil).

8 STAFF NUMBERS

The average number of employees (head count based on number of staff employed) during the year was 47 (2021: 49).

9 RELATED PARTY TRANSACTIONS

There are no donations from related parties which are outside the normal course of business and no restricted donations from related parties.

Trustees of Movember Europe serve in a voluntary capacity and are not remunerated for their duties as a trustee. One Trustee, Nicholas Reece, is remunerated as the Chairperson of Movember Group Pty Limited. The total of his remuneration was £42,457 (2021: £48,386).

There were no balances outstanding at year end. Remuneration of trustees in an executive capacity is permitted by the Charity’s governing document.

Decisions regarding the remuneration of the above are made by the other members of the trustee board with no input from the affected individuals.

As a member of the global Movember Group, Movember Europe incurs costs on behalf of, and is recharged costs by other members of the Movember Group. A summary of the amounts reallocated between other group entities and Movember Europe and the balance outstanding at the year end is shown below.

Current Year	Expenses	Expenses	Donation	Balance owed to/
	reallocated to	reallocated from	to parent	(from) charity at
	the charity(£)	the charity(£)	charity(£)	theyear end (£)
MOVEMBER FOUNDATION	6,445,288	3,715,554	-	160,594
MOVEMBER FOUNDATION E.V (MOVEMBER GERMANY)	104,791	50,784	-	10,518
MOVEMBER EUROPE TRADING LTD	813,694	924,509	1,780,208	1,798,770
MOVEMBER USA	233,910	270,694	-	(5,168)
MOVEMBER CANADA	7,332	53,627	-	-
MOVEMBER FOUNDATION NEW ZEALAND	17,019	413	-	-
Prior Year	Expenses	Expenses	Donation	Balance owed to/
	reallocated to	reallocated from	to parent	(from) charity at
	the charity(£)	the charity(£)	charity(£)	theyear end (£)
MOVEMBER FOUNDATION	4,573,551	4,183,165	-	332,881
MOVEMBER FOUNDATION E.V (MOVEMBER GERMANY)	354,143	62,535	-	(8,094)
MOVEMBER EUROPE TRADING LTD	133,356	190,293	833,579	869,473
MOVEMBER USA	215,492	139,620	-	(64,278)
MOVEMBER CANADA	5,091	254,703	-	80,122
MOVEMBER FOUNDATION NEW ZEALAND	14,872	18,710	-	988

40 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

10 TAXATION

The charity is exempt from corporation tax as all its income is charitable and is applied for charitable purposes. The charity and so no tax is due. Movember Foundation e.V. is a registered association in Germany and is not subject to tax on any surplus generated during the year.

11 TANGIBLE FIXED ASSETS

The group and	Leasehold	Fixtures and	Fixtures and	Fixtures and	Computer	Total (£)
the charity	improvements (£)				equipment (£)
COST
AT THE START OF THE YEAR	410,915			66,894	216,413	694,222
ADDITIONS IN YEAR	-			-	6,789	6,789
DISPOSALS IN YEAR	-			-	-	-
LOSS ON FOREIGN EXCHANGE	-			(119)	(368)	(487)
AT THE END OF THE YEAR	410,915			66,775	222,834	700,524
DEPRECIATION
AT THE START OF THE YEAR	312,613			65,074	198,137	575,824
CHARGE FOR THE YEAR	82,955			776	14,009	97,740
ELIMINATED ON DISPOSAL	-			-	-	-
LOSS ON FOREIGN EXCHANGE	-			(119)	(321)	(440)
AT THE END OF THE YEAR	395,568			65,731	211,825	673,124
NET BOOK VALUE
AT THE END OF THE YEAR	15,347			1,044	11,009	27,400
AT THE START OF THE YEAR	98,302			1,820	18,276	118,398

All of the above assets are used for charitable purposes.

12 INVESTMENTS

Investments are represented by bank term deposits with maturities of greater than one year.

41 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

13A SUBSIDIARY UNDERTAKINGS

MOVEMBER EUROPE TRADING LIMITED

The charity owns the whole of the issued ordinary share capital of Movember Europe Trading Limited, a company Rosebery Avenue, London, England, EC1R 4RP.

The subsidiary is used for non-primary purpose trading activities. All activities have been consolidated on a line by line

A summary of the results of the subsidiary is shown below:

	2022 (£)	2021 (£)
TURNOVER	1,942,202	1,036,288
PROGRAMME EXPENDITURE	(54,984)	(75,965)
ADMINISTRATIVE EXPENSES	(40,811)	(29,061)
FUNDRAISING	(53,345)	(81,027)
PROFIT ON ORDINARY ACTIVITIES BEFORE INTEREST AND TAXATION	1,793,062	850,235
(LOSS) ON FOREIGN EXCHANGE	(12,854)	(16,656)
PROFIT ON ORDINARY ACTIVITIES BEFORE TAXATION	1,780,208	833,579
TAXATION ON PROFIT ON ORDINARY ACTIVITIES	-	-
GIFT AID TO PARENT	(1,780,208)	(833,579)
PROFIT FOR THE FINANCIAL YEAR	-	-
THE AGGREGATE OF THE ASSETS, LIABILITIES AND RESERVES WAS:
ASSETS	1,803,588	875,219
LIABILITIES	(1,803,587)	(875,218)
RESERVES	1	1

Amounts owed to/from the parent undertaking are shown in note 9.

42 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

13A SUBSIDIARY UNDERTAKINGS (CONTINUED)

MOVEMBER FOUNDATION E.V. - RESULTS OF OPERATIONS

The charitable company also controls Movember Foundation e.V. an association registered in Germany. The subsidiary is used for carrying out the Movember campaign in Germany. All activities have been consolidated on a line by line basis using the presentational currency of Euros.

	2022 (€)	2021 (€)
TURNOVER	805,448	1,139,482
ADMINISTRATIVE EXPENSES	(77,164)	(61,659)
FUNDRAISING COSTS	(117,944)	(108,343)
MEN'S HEALTH PROGRAMMES	(346,271)	(310,227)
PROFIT ON ORDINARY ACTIVITIES BEFORE INTEREST AND TAXATION	264,070	659,252
(LOSS) ON FOREIGN EXCHANGE	(2,146)	(4,634)
PROFIT ON ORDINARY ACTIVITIES BEFORE TAXATION	261,924	654,618
TAXATION ON PROFIT ON ORDINARY ACTIVITIES	-	-
PROFIT FOR THE FINANCIAL YEAR	261,924	654,618
THE AGGREGATE OF THE ASSETS, LIABILITIES AND RESERVES WAS:
ASSETS	2,703,413	2,377,113
LIABILITIES	(87,977)	(23,601)
RESERVES	2,615,436	2,353,512

13B BRANCHES - MOVEMBER IRELAND - RESULTS OF OPERATIONS

Movember Europe was registered as a charity in Ireland (charity no. 20105280) on 22 March 2018. The activities are not carried out within a separate entity but are instead treated as a branch of the charity. The results of the Ireland operations for the year ended 30 April 2022 were as follows:

	2022 (€)	2021 (€)
REVENUE	2,687,944	4,946,947
TOTAL COSTS	(1,505,215)	(760,204)
NET INCOME BEFORE OTHER RECOGNISED GAINS AND LOSSES	1,182,728	4,186,743
(LOSS) / GAIN ON FOREIGN EXCHANGE	(6,033)	3,872
NET MOVEMENT IN FUNDS	1,176,696	4,190,614
THE AGGREGATE OF THE ASSETS, LIABILITIES AND RESERVES WAS:
ASSETS	7,833,340	6,572,496
LIABILITIES	(596,064)	(490,409)
RESERVES	7,237,276	6,082,087

43 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

14 PARENT CHARITY

The parent charity’s gross income and the results for the year are disclosed as follows:

	2022 (£)	2021 (£)
GROSS INCOME	18,776,491	25,633,481
RESULT FOR THE YEAR	7,626,537	15,146,172

15 DEBTORS

15 DEBTORS
		The group		The charity
	2022 (£)	2021 (£)	2022 (£)	2021 (£)
TRADE DEBTORS	754,973	580,764	83,889	-
OTHER DEBTORS	68,252	63,859	67,133	63,133
GIFT AID RECEIVABLE	900,934	1,749,542	900,934	1,749,542
AMOUNTS DUE FROM GROUP UNDERTAKINGS	181,322	419,940	1,969,882	1,283,464
PREPAYMENTS	118,581	93,377	118,581	93,377
ACCRUED INCOME	110,805	164,086	107,394	163,505
	2,134,867	3,071,568	3,247,812	3,353,022

16 CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

		The group		The charity
	2022 (£)	2021 (£)	2022 (£)	2021 (£)
MEN'S HEALTH PARTNER GRANT
DISTRIBUTIONS PAYABLE	8,026,081	11,316,180	8,026,081	11,316,180
TRADE CREDITORS	358,089	268,379	358,089	266,615
TAXATION AND SOCIAL SECURITY	150,112	157,129	92,245	142,248
OTHER CREDITORS	158,964	173,970	158,964	173,970
AMOUNTS DUE TO GROUP ENTITIES	4,926	63,487	4,861	72,300
ACCRUALS	501,630	677,352	491,459	667,725
	9,199,801	12,656,498	9,131,699	12,639,038

17 CREDITORS: AMOUNTS FALLING DUE AFTER ONE YEAR

			The group		The charity
		2022 (£)	2021 (£)	2022 (£)	2021 (£)
LEASE	LIABILITIES	63,238	70,926	63,238	70,926
OTHER	LIABILITIES	129,888	-	129,888	-
		193,126	70,926	193,126	70,926

44 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

18A ANALYSIS OF GROUP NET ASSETS BETWEEN FUNDS (CURRENT YEAR)

	General	Designated	Restricted	Total
	unrestricted (£)	funds (£)	funds (£)	funds (£)
TANGIBLE FIXED ASSETS	27,400	-	-	27,400
INVESTMENTS	-	-	-	-
NET CURRENT ASSETS	6,641,726	34,921,236	957,432	42,520,394
LONG TERM LIABILITIES	(193,126)	-	-	(193,126)
NET ASSETS AT 30 APRIL 2022	6,476,000	34,921,236	957,432	42,354,668

18B ANALYSIS OF GROUP NET ASSETS BETWEEN FUNDS (PRIOR YEAR)

	General	Designated	Restricted	Total
	unrestricted (£)	funds (£)	funds (£)	funds (£)
TANGIBLE FIXED ASSETS	118,398	-	-	118,398
INVESTMENTS	2,500,000	-	-	2,500,000
NET CURRENT ASSETS	4,446,083	27,486,463	546,312	32,478,858
LONG TERM LIABILITIES	(70,926)	-	-	(70,926)
NET ASSETS AT 30 APRIL 2021	6,993,555	27,486,463	546,312	35,026,330

19A MOVEMENTS IN FUNDS (CURRENT YEAR)

	At 1 May 2021	Income &	Expenditure	Transfers	At 30 April
	(£)	gains (£)	& losses (£)	(£)	2022 (£)
RESTRICTED FUNDS:
L’ORÉAL	-	312,987	-	-	312,987
MR PORTER	74,339	79,521	(25,608)	-	128,252
HARLEQUINS	81,439	-	(61,858)	-	19,581
GILLETTE	390,534	348,644	(351,466)	-	387,712
ROYAL HIGHLAND AND AGRICULTURAL
SOCIETY OF SCOTLAND	-	50,000	-	-	50,000
ST HELENS COUNCIL	-	58,900	-	-	58,900
ANDREW EVANS	-	7,500	(7,500)	-	-
TOTAL RESTRICTED FUNDS	546,312	857,552	(446,432)	-	957,432
UNRESTRICTED FUNDS:
DESIGNATED FUNDS:
MEN'S HEALTH PROGRAMME(S)	27,486,463	8,686,749	(1,251,976)	-	34,921,236
TOTAL DESIGNATED FUNDS	27,486,463	8,686,749	(1,251,976)	-	34,921,236
GENERAL FUNDS	6,993,555	10,078,633	(10,596,188)	-	6,476,000
TOTAL UNRESTRICTED FUNDS	34,480,018	18,765,382	(11,848,164)	-	41,397,236
TOTAL FUNDS	35,026,330	19,622,934	(12,294,596)	-	42,354,668

The narrative to explain the purpose of each fund is given at the foot of the note below.

45 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

19B MOVEMENTS IN FUNDS (PRIOR YEAR)

	At 1 May 2020	Income &	Expenditure	Transfers	At 30 April
	(£)	gains (£)	& losses (£)	(£)	2021 (£)
RESTRICTED FUNDS:
FERO	-	86,381	(86,381)	-	-
L'ORÉAL	224,014	-	(224,014)	-	-
MR PORTER	16,250	57,853	-	236	74,339
HARLEQUINS	61,851	19,588	(47,928)	47,928	81,439
GILLETTE	-	390,534	-	-	390,534
RUGBY LEAGUE WORLD CUP	-	10,000	(10,000)	-	-
TOTAL RESTRICTED FUNDS	302,115	564,356	(368,323)	48,164	546,312
UNRESTRICTED FUNDS:
DESIGNATED FUNDS:
MEN'S HEALTH PROGRAMME(S)	11,720,568	18,603,555	(2,837,660)	-	27,486,463
TOTAL DESIGNATED FUNDS	11,720,568	18,603,555	(2,837,660)	-	27,486,463
GENERAL FUNDS	7,319,816	7,683,139	(7,961,236)	(48,164)	6,993,555
TOTAL UNRESTRICTED FUNDS	19,040,384	26,286,694	(10,798,896)	(48,164)	34,480,018
TOTAL FUNDS	19,342,499	26,851,050	(11,167,219)	-	35,026,330

international academic research programme lead by Dr Zac Seidler, Research Fellow at Orygen and Centre for Youth Mental Health, University of Melbourne

The Mr Porter Health in Mind fund, powered by Movember, will go towards men’s Mental Health initiatives, in accordance Health & Wellbeing App for Men in Scotland

The funds received from Harlequins and Andrew Evans will be used for delivery of Ahead of the Game, a Movember project aimed at improving youth mental health through community organised sport by engaging with the whole community around the local sports club.

The funds received from Gillette will be used for the delivery of our Veterans and First Responders project, aimed at

The funds received from the Royal Highland and Agricultural Society of Scotland will be used for the Farmstrong Scotland program. Farmstrong is an early intervention wellbeing programme that takes the science of wellbeing to rural communities.

The funds received from St Helens Council will be used for an Ahead of the Game School Sports pilot in St Helens, awarded by the St Helens Council Public Health - Prevention and Promotion of Better Mental Health Fund 2021-22.

PURPOSES OF DESIGNATED FUNDS

Men’s Health Programme.

This represents funds which the trustees intend to fund all of Movember’s men’s health programmes.

46 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022

MOVEMBER EUROPE NOTES TO THE FINANCIAL STATEMENTS

20 OPERATING LEASE COMMITMENTS PAYABLE AS A LESSEE

The group’s total future minimum lease payments under non-cancellable operating leases is as follows for each of the following periods:

		Property		Equipment
	2022 (£)	2021 (£)	2022 (£)	2021 (£)
LESS THAN ONE YEAR	279,158	279,294	892	1,784
ONE TO FIVE YEARS	1,047,600	65,475	-	892
OVER FIVE YEARS	-	-	-	-
	1,326,758	344,769	892	2,676

21 PARENT COMPANY

The sole member and ultimate parent undertaking is the Movember Foundation, an Australian charitable organisation.

22 LEGAL STATUS OF THE CHARITY

The charity is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up is limited to £1.

47 REPORT AND FINANCIAL STATEMENTS FOR YEAR ENDED 30 APRIL 2022